582 | 582 5 58 582 582 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
Chem Biol chem C Ch Che Chem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .;:-. 5 10 0 1 0 0 1
wileyonlinelibrary.com/journal/cbdd wileyonlinelibrary.com/journal/cbdd wileyonlinelibrary.com/journal/cbdd w wi wil wile BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .// 3 9 0 1 0 0 1
1 | 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
The formyl the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 () 2 9 0 1 0 0 1
protein-coupled receptors protein-coupled p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 10 0 1 0 0 1
host defense host h ho hos host BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.,; 4 10 0 1 0 0 1
et al., et e et et et BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 .,).- 5 8 0 0 0 0 1
mans: FPR1, mans: m ma man mans BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 :,,., 5 8 0 0 0 0 1
the family the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 10 0 0 0 0 1
transduce the transduce t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
product, formyl-methionine-leucyl-phenylalanine product, p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,---(; 6 8 0 0 0 0 1
Boulay et boulay B Bo Bou Boul BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 .,). 4 9 0 0 0 0 1
Received: 3 received: R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ::: 3 10 0 1 0 0 1
DOI: 10.1111/cbdd.13913 doi: D DO DOI DOI: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 :./. 4 10 0 1 0 0 1
R E r R R R R BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 2 no 0 10 0 1 0 0 1
Synthesis, biological synthesis, S Sy Syn Synt BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 ,,, 3 8 0 0 0 0 1
structural analysis structural s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
N-formyl peptide n-formyl N N- N-f N-fo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 - 1 5 0 0 0 0 1
Claudia Vergelli claudia C Cl Cla Clau BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 3 . 1 9 0 0 0 0 1
| | | | | | | BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 3 no 0 0 0 0 0 0 1
Niccolò Cantini niccolò N Ni Nic Nicc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 .. 2 10 0 0 0 0 1
Mark T. mark M Ma Mar Mark BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 3 . 1 8 0 0 0 0 1
This is this T Th Thi This BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,,, 3 10 0 1 0 0 1
work is work w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 1 0 1 0 0 1
© 2021 © © © © © BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 4 .. 2 4 0 1 0 0 1
1 Neurofarba, 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 5 , 1 10 0 0 0 0 1
Nutraceutical Section, nutraceutical N Nu Nut Nutr BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 , 1 9 0 0 0 0 1
Florence, Sesto florence, F Fl Flo Flor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 ,, 2 8 0 0 0 0 1
2 National 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
University, Tomsk, university, U Un Uni Univ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ,, 2 7 0 0 0 0 1
3 Department 3 3 3 3 3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
Immunology, Montana immunology, I Im Imm Immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 ,, 2 8 0 0 0 0 1
Bozeman, MT, bozeman, B Bo Boz Boze BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 ,, 2 3 0 0 0 0 1
4 Institute 4 4 4 4 4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 6 ,' 2 10 0 0 0 0 1
College London, college C Co Col Coll BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 ,, 2 6 0 0 0 0 1
5 Department 5 5 5 5 5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 6 , 1 10 0 0 0 0 1
University of university U Un Uni Univ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 ,, 2 10 0 0 0 0 1
Correspondence Correspondence correspondence C Co Cor Corr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 3 0 0 0 0 1
Letizia Crocetti, letizia L Le Let Leti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 ,, 2 9 0 0 0 0 1
Pharmaceutical and pharmaceutical P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 10 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 ,, 2 10 0 0 0 0 1
Italy. Italy. italy. I It Ita Ital BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 . 1 1 0 0 0 0 1
Email: letizia.crocetti@unifi.it email: E Em Ema Emai BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 :.@. 4 7 0 0 0 0 1
Funding information funding F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 4 0 0 0 0 1
This study this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
Institutes of institutes I In Ins Inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
of Health of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 7 0 0 0 0 1
GM115371 and gm115371 G GM GM1 GM11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 7 no 0 8 0 0 0 0 1
Polytechnic University polytechnic P Po Pol Poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 0 0 0 0 1
Enhancement Program enhancement E En Enh Enha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 (- 2 9 0 0 0 0 1
SAMT-208/2020). SAMT-208/2020). samt-208/2020). S SA SAM SAMT BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 7 -/). 4 3 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 10 0 0 0 0 1
N-formyl peptide n-formyl N N- N-f N-fo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 -(,,) 5 10 0 0 0 0 1
of inflammatory of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,, 2 10 0 0 0 0 1
have a have h ha hav have BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 /., 3 10 0 0 0 0 1
represent an represent r re rep repr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 - 1 10 0 0 0 0 1
flammatory diseases. flammatory f fl fla flam BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 ., 2 10 0 0 0 0 1
pyridazinone or pyridazinone p py pyr pyri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 -() 3 10 0 0 0 0 1
fragment, which fragment, f fr fra frag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ,.- 3 10 0 0 0 0 1
zolone derivatives zolone z zo zol zolo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 -, 2 10 0 0 0 0 1
exhibiting the exhibiting e ex exh exhi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 -. 2 10 0 0 0 0 1
low or low l lo low low BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 10 ,- 2 10 0 0 0 0 1
propriate for propriate p pr pro prop BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 . 1 10 0 0 0 0 1
studies, which studies, s st stu stud BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 ,- 2 10 0 0 0 0 1
worse arrangement worse w wo wor wors BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 . 1 10 0 0 0 0 1
K E k K K K K BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 11 no 0 10 0 0 0 0 1
Agonist, cancer, agonist, A Ag Ago Agon BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ,,,,,, 6 10 0 0 0 0 1
| 583 | | | | | BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 10 0 1 1 1 1
the immune the t th the the BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,/- 3 9 0 0 0 0 1
rophages, but rophages, r ro rop roph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,,- 4 9 0 0 0 0 1
testinal tract. testinal t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ., 2 9 0 0 0 0 1
is also is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,,- 4 9 0 0 0 0 1
trocytes (Compernolle trocytes t tr tro troc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (.,;.,; 7 9 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,).,, 6 9 0 0 0 0 1
and its and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 9 0 0 0 0 1
phages, and phages, p ph pha phag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,( 2 9 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,,). 5 3 0 0 0 0 1
The primary the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
in response in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
it also it i it it it BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
trophils (Wen trophils t tr tro trop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (.,)., 6 9 0 0 0 0 1
been shown been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 /- 2 9 0 0 0 0 1
sion of sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,- 3 9 0 0 0 0 1
cated in cated c ca cat cate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
and neuroblastoma and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.,;.,; 7 9 0 0 0 0 1
Maris, 2010; maris, M Ma Mar Mari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,;.,),- 7 8 0 0 0 0 1
mote the mote m mo mot mote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 0 0 (.,). 5 9 0 0 0 0 1
Conversely, FPR1 conversely, C Co Con Conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
suppressor properties suppressor s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.,) 4 10 0 0 0 0 1
and melanoma and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.,),. 6 9 0 0 0 0 1
Interestingly, depending interestingly, I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 0 0 0 0 1
can have can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
as some as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
infection, while infection, i in inf infe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-- 3 10 0 0 0 0 1
inflammatory pathways. inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ., 2 9 0 0 0 0 1
switch between switch s sw swi swit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --- 3 8 0 0 0 0 1
cell responses cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
ceptor following ceptor c ce cep cept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 :,- 3 9 0 0 0 0 1
inflammatory mediators inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 8 0 0 0 0 1
lipoxin A4 lipoxin l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ()- 3 8 0 0 0 0 1
tion and tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -, 2 9 0 0 0 0 1
neutrophil apoptosis, neutrophil n ne neu neut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,(- 3 9 0 0 0 0 1
Semrl et semrl S Se Sem Semr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .,)., 5 9 0 0 0 0 1
as serum as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
tion, and tion, t ti tio tion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
expression of expression e ex exp expr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 8 0 0 0 0 1
(Cooray et (cooray ( (C (Co (Coo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 (.,;,). 7 6 0 0 0 0 1
Currently, the currently, C Cu Cur Curr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ,- 2 8 0 0 0 0 1
macological target macological m ma mac maco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 , 1 9 0 0 0 0 1
as inflammatory as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,-, 3 9 0 0 0 0 1
neuroinflammation, and neuroinflammation, n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,(.,; 5 8 0 0 0 0 1
Burli et burli B Bu Bur Burl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 .,;.,;.,; 9 9 0 0 0 0 1
Liu et liu L Li Liu Liu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 5 .,;,;.,; 8 9 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 .,,;.,;.,). 11 9 0 0 0 0 1
Despite the despite D De Des Desp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 9 0 0 0 0 1
recent years, recent r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,- 2 9 0 0 0 0 1
ized in ized i iz ize ized BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 , 1 8 0 0 0 0 1
even less even e ev eve even BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 0 0 0 0 1
two interesting two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 :, 2 8 0 0 0 0 1
and exhibiting and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 9 0 0 0 0 1
matoid arthritis matoid m ma mat mato BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 (.,;.,), 8 9 0 0 0 0 1
and compound and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -, 2 8 0 0 0 0 1
I clinical i I I I I BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 5 , 1 10 0 0 0 0 1
healthy human healthy h he hea heal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 (.,;.,). 8 9 0 0 0 0 1
Our research our O Ou Our Our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 9 0 0 0 0 1
large number large l la lar larg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 5 ,// 3 8 0 0 0 0 1
FPR3 agonists, fpr3 F FP FPR FPR3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 ,-- 3 8 0 0 0 0 1
(Cilibrizzi et (cilibrizzi ( (C (Ci (Cil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 (.,,,;.,; 9 9 0 0 0 0 1
Giovannoni et giovannoni G Gi Gio Giov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 .,).- 5 9 0 0 0 0 1
ferent scaffolds, ferent f fe fer fere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,-(-) 5 9 0 0 0 0 1
acetamide fragment. acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ., 2 7 0 0 0 0 1
EC 50 ec E EC EC EC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 , 1 8 0 0 0 0 1
pyridazin-3(2H)-one derivatives pyridazin-3(2h)-one p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 -()-(.,), 9 9 0 0 0 0 1
EC3 (Vergelli ec3 E EC EC3 EC3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 (.,),( 6 9 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 .,;). 5 8 0 0 0 0 1
evaluated in evaluated e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 9 0 0 0 0 1
were found were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -( 2 8 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 .,). 4 2 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 5 , 1 8 0 0 0 0 1
of these of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,- 2 9 0 0 0 0 1
membered pyrazoles membered m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ()() 4 8 0 0 0 0 1
analogues of analogues a an ana anal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 8 0 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 11 no 0 10 0 1 0 0 1
agonists agonists agonists a ag ago agon BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 no 0 2 0 1 0 0 1
584 | 584 5 58 584 584 BLOCKSTART PAGESTART SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 10 0 1 1 0 1
(Vergelli et (vergelli ( (V (Ve (Ver BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (.,,)( 6 9 0 1 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,)- 4 9 0 1 0 0 1
side group. side s si sid side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 10 0 1 0 0 1
4-bromophenylacetamide side 4-bromophenylacetamide 4 4- 4-b 4-br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 - 1 10 0 1 0 0 1
compounds of compounds c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (). 3 5 0 1 0 0 1
2 | 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 1 no 0 10 0 0 0 0 1
2.1 | 2.1 2 2. 2.1 2.1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 . 1 10 0 0 0 0 1
Reagents and reagents R Re Rea Reag BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 - 1 8 0 0 0 0 1
mercial sources. mercial m me mer merc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ., 2 10 0 0 0 0 1
solvents were solvents s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 .- 2 8 0 0 0 0 1
tions were tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 -() 3 9 0 0 0 0 1
using commercial using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
F-254. Visualization f-254. F F- F-2 F-25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 -. 2 8 0 0 0 0 1
(λ max (λ ( (λ (λ (λ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ().- 4 8 0 0 0 0 1
formed on formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
(Kieselgel 40, (kieselgel ( (K (Ki (Kie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 (,.-.;)- 8 9 0 0 0 0 1
raphy (Kieselgel raphy r ra rap raph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 (,.-.;). 8 9 0 0 0 0 1
chromatographically and chromatographically c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 , 1 9 0 0 0 0 1
unless otherwise unless u un unl unle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 .- 2 8 0 0 0 0 1
ing IUPAC ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 0 1 ,- 2 9 0 0 0 0 1
2000 (4.01.305) 2000 2 20 200 2000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 1 (..). 5 9 0 0 0 0 1
determined on determined d de det dete BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
are uncorrected. are a ar are are BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 10 0 1 0 0 1
final compounds final f fi fin fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 1 0 0 1
chromatography. 1 chromatography. c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .,, 3 8 0 1 0 0 1
spectra were spectra s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ( 1 9 0 1 0 0 1
Biospin Version biospin B Bi Bio Bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 ,.). 4 9 0 1 0 0 1
(δ) are (δ) ( (δ (δ) (δ) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (). 3 10 0 1 0 0 1
as the as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .() 3 9 0 1 0 0 1
given in given g gi giv give BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 '.'- 4 9 0 1 0 0 1
ware (Nicolet ware w wa war ware BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 5 (.,,) 5 9 0 1 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ..(/) 5 9 0 1 0 0 1
ESI-MS triple esi-ms E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 -(), 4 9 0 1 0 0 1
ion mode, ion i io ion ion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,/- 3 9 0 1 0 0 1
solved in solved s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ::/. 4 10 0 1 0 0 1
compounds had compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ; 1 9 0 1 0 0 1
the symbols the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 1 0 0 1
Elmer 260 elmer E El Elm Elme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 1 5 ,,, 3 9 0 1 0 0 1
within ±0.4% within w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .. 2 6 0 1 0 0 1
2.2 | 2.2 2 2. 2.2 2.2 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 . 1 10 0 0 0 0 1
new compounds new n ne new new BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 10 0 0 0 0 1
2.2.1 | 2.2.1 2 2. 2.2 2.2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 ..- 3 10 0 0 0 0 1
A mixture a A A A A BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 10 - 1 9 0 0 0 0 1
mediate of mediate m me med medi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 (-;.),(.), 10 10 0 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 11 ,, 2 10 0 1 0 0 1
and 2a and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 9 0 1 0 0 1
products A products p pr pro prod BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 4 0 1 0 0 1
| 585 | | | | | BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 10 0 1 1 0 1
and N-(4-bromophenyl)-2-chloroacetamide and a an and and BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -(-)--(; 8 7 0 1 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .,;.-.)(-) 10 8 0 1 0 0 1
refluxed under refluxed r re ref refl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -. 2 9 0 1 0 0 1
concentrated in concentrated c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,-, 3 8 0 1 0 0 1
precipitate was precipitate p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 8 0 1 0 0 1
purified by purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 1 0 0 1
hexane/ethyl acetate hexane/ethyl h he hex hexa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 /:,/: 5 10 0 1 0 0 1
3b, and 3b, 3 3b 3b, 3b, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ,/:. 4 6 0 1 0 0 1
2-(5-Amino-4-cyanopyrazol-1-yl)-N-(4-bromophenyl) 2-(5-Amino-4-cyanopyrazol-1-yl)-N-(4-bromophenyl) 2-(5-amino-4-cyanopyrazol-1-yl)-n-(4-bromophenyl) 2 2- 2-( 2-(5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -(-----)--(-) 13 10 0 0 0 0 1
acetamide, 3a acetamide, a ac ace acet BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 2 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ;-();-(, 8 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -).(,,),.(,,), 14 9 0 0 0 0 1
7.49 (m, 7.49 7 7. 7.4 7.49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 .(,:,;,),.(,, 13 8 0 0 0 0 1
NH). ESI-MS nh). N NH NH) NH). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ).-.,.;:/ 9 9 0 0 0 0 1
320.91 [M 320.91 3 32 320 320. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 .[]...:., 9 10 0 0 0 0 1
3.15, N 3.15, 3 3. 3.1 3.15 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 .,..:.,.,.. 11 7 0 0 0 0 1
2-(5-Amino-4-methyl-3-phenylpyrazol-1-yl)-N-(4- 2-(5-Amino-4-methyl-3-phenylpyrazol-1-yl)-N-(4- 2-(5-amino-4-methyl-3-phenylpyrazol-1-yl)-n-(4- 2 2- 2-( 2-(5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 -(-------)--(- 14 10 0 0 0 0 1
bromophenyl)acetamide, 3b bromophenyl)acetamide, b br bro brom BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 ), 2 5 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 ;-();-(, 8 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 -).(,,),.(,,),. 15 9 0 0 0 0 1
(exch br (exch ( (e (ex (exc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 (,,),.(,,),.(,,), 17 9 0 0 0 0 1
7.48 (d, 7.48 7 7. 7.4 7.48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 .(,.,,),.(,,),.( 16 9 0 0 0 0 1
s, 1H, s, s s, s, s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 ,,).-.,.;: 10 10 0 0 0 0 1
m/z 386.01 m/z m m/ m/z m/z BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 /.[]....: 9 9 0 0 0 0 1
56.12, H 56.12, 5 56 56. 56.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 .,.,..:.,.,.. 13 8 0 0 0 0 1
2-(5-Aminopyrazol-1-yl)-N-(4-bromophenyl)acetamide, 2-(5-Aminopyrazol-1-yl)-N-(4-bromophenyl)acetamide, 2-(5-aminopyrazol-1-yl)-n-(4-bromophenyl)acetamide, 2 2- 2-( 2-(5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 3 -(---)--(-), 12 10 0 0 0 0 1
3c 3c 3c 3 3c 3c 3c BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 3 no 0 0 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 3 ;-();-(, 8 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 -).(,,),.(,,), 14 10 0 0 0 0 1
5.26 (d, 5.26 5 5. 5.2 5.26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 3 .(,.,,),.(,.,, 14 9 0 0 0 0 1
pyrazole), 7.47 pyrazole), p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 3 ),.(,.,,),.(,., 15 9 0 0 0 0 1
2H, Ar), 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 3 ,),.(,,).-. 11 8 0 0 0 0 1
C 11 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 ,.;:/.[].. 10 9 0 0 0 0 1
Calcd. for. calcd. C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 3 ..:.,.,..: 10 10 0 0 0 0 1
C 44.89, c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 3 .,.,.. 6 4 0 0 0 0 1
2.2.2 | 2.2.2 2 2. 2.2 2.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ..- 3 10 0 0 0 0 1
A mixture a A A A A BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 4 (-; 3 9 0 0 0 0 1
0.31 mmol), 0.31 0 0. 0.3 0.31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 .),--(.- 8 7 0 0 0 0 1
0.93 mmol), 0.93 0 0. 0.9 0.93 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 .),(.),- 8 9 0 0 0 0 1
amine (0.62 amine a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 (.),(, 6 9 0 0 0 0 1
4 Å) 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 4 )()- 4 9 0 0 0 0 1
perature for perature p pe per pera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 -.; 3 9 0 0 0 0 1
solution was solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 () 2 8 0 0 0 0 1
and water and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (). 3 10 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 , 1 9 0 0 0 0 1
were purified were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 - 1 9 0 0 0 0 1
ents cyclohexane/ethyl ents e en ent ents BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 /:,/ 4 9 0 0 0 0 1
ethyl acetate ethyl e et eth ethy BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 5 :,/ 3 9 0 1 0 0 1
9.8:0.2 for 9.8:0.2 9 9. 9.8 9.8: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .:.,/:. 7 10 0 1 0 0 1
N-(4-Bromophenyl)-2-[4-cyano-5-(3- N-(4-Bromophenyl)-2-[4-cyano-5-(3- n-(4-bromophenyl)-2-[4-cyano-5-(3- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 -(-)--[---(- 12 7 0 1 0 0 1
methoxyphenylamino)pyrazol-1-yl]acetamide, 4a methoxyphenylamino)pyrazol-1-yl]acetamide, m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 )--], 5 10 0 1 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 ;;-(,).(, 9 8 0 1 0 0 1
3H, OCH 3h, 3 3H 3H, 3H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 ,),.(,,),.(,,),.(, 18 9 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 5 .,,),.(,.,,),. 14 8 0 1 0 0 1
(exch br (exch ( (e (ex (exc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (,,),.(,.,,),.(, 16 8 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 5 .,,),.(,.,,),.(,, 17 9 0 1 0 0 1
pyrazole), 8.24 pyrazole), p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ),.(,,).-(, 11 8 0 1 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 -).,.,.,.,.,., 14 8 0 1 0 0 1
112.89, 118.51, 112.89, 1 11 112 112. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .,.,.,.,.,.,., 14 8 0 1 0 0 1
142.65, 147.51, 142.65, 1 14 142 142. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .,.,.,..-. 10 7 0 1 0 0 1
C 19 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 5 ,.;:/.[].. 10 9 0 1 0 0 1
Calcd. for. calcd. C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 ..:.,.,..: 10 10 0 1 0 0 1
C 53.38, c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 5 .,.,.. 6 3 0 1 0 0 1
N-(4-Bromophenyl)-2-[4-cyano-5-(4- N-(4-Bromophenyl)-2-[4-cyano-5-(4- n-(4-bromophenyl)-2-[4-cyano-5-(4- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 -(-)--[---(- 12 7 0 0 0 0 1
methoxyphenylamino)pyrazol-1-yl]acetamide, 4b methoxyphenylamino)pyrazol-1-yl]acetamide, m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 )--], 5 10 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 ;-();-(, 8 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 7 ).(,,),.(,,),.(, 16 10 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 .,,),.(,.,,),.( 15 9 0 0 0 0 1
br s, br b br br br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 ,,),.(,,),.(,.,,), 18 9 0 0 0 0 1
7.69 (s, 7.69 7 7. 7.6 7.69 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 .(,,),.(,,).- 13 9 0 0 0 0 1
(100 MHz, (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 (,).,.,.,.,., 13 9 0 0 0 0 1
118.51, 122.07, 118.51, 1 11 118 118. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 .,.,.,.,.,.,., 14 8 0 0 0 0 1
147.51, 160.81, 147.51, 1 14 147 147. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 .,.,..-., 9 10 0 0 0 0 1
426.27; found: 426.27; 4 42 426 426. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 .;:/.[].... 11 8 0 0 0 0 1
C 19 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 :.,.,..:., 10 10 0 0 0 0 1
H 3.79, h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 .,.. 4 2 0 0 0 0 1
N-(4-Bromophenyl)-2-[5-(3-methoxyphenylamino)-4- N-(4-Bromophenyl)-2-[5-(3-methoxyphenylamino)-4- n-(4-bromophenyl)-2-[5-(3-methoxyphenylamino)-4- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 -(-)--[-(-)-- 13 10 0 0 0 0 1
methyl-3-phenylpyrazol-1-yl]acetamide, 4c methyl-3-phenylpyrazol-1-yl]acetamide, m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 ----], 6 8 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 ;.();- 6 6 0 0 0 0 1
(400 MHz, (400 ( (4 (40 (400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 (,-).(,,),.(,, 14 8 0 0 0 0 1
OCH 3 och O OC OCH OCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 ),.(,,),.(,,),.(, 17 8 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 .,,),.(,,),.(,,),. 18 9 0 0 0 0 1
(m, 2H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 (,,),.(,,),.(,,),.( 19 9 0 0 0 0 1
s, 1H, s, s s, s, s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 ,,),.(,,).-(, 13 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 ).,.,.,.,.,.,., 15 9 0 0 0 0 1
117.42, 121.61, 117.42, 1 11 117 117. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 .,.,.,.,.,.,., 14 8 0 0 0 0 1
133.17, 136.19, 133.17, 1 13 133 133. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 .,.,.,.,.,.,.. 14 8 0 0 0 0 1
ESI-MS calcd. esi-ms E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 -.,.;:/. 8 9 0 0 0 0 1
[M + [m [ [M [M [M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 []...:.,., 10 10 0 0 0 0 1
N 11.40. n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 ..:.,.,.. 9 6 0 0 0 0 1
N-(4-Bromophenyl)-2-[5-(4-methoxyphenylamino)-4- N-(4-Bromophenyl)-2-[5-(4-methoxyphenylamino)-4- n-(4-bromophenyl)-2-[5-(4-methoxyphenylamino)-4- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 -(-)--[-(-)-- 13 10 0 0 0 0 1
methyl-3-phenylpyrazol-1-yl]acetamide, 4d methyl-3-phenylpyrazol-1-yl]acetamide, m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 ----], 6 8 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 ;-();-(, 8 8 0 0 1 1 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 -).(,,),.(,,),.(, 17 10 0 0 0 0 1
2H, NCH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 ,),.(,.,,),.(,., 16 9 0 0 0 0 1
2H, Ar), 2h, 2 2H 2H, 2H, BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 ,),.(,,),.(,,),.(,: 19 8 0 0 0 0 1
586 | 586 5 58 586 586 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 10 0 1 1 0 1
3H, Ar; 3h, 3 3H 3H, 3H, BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ,;,,),.(,,),.( 14 9 0 1 0 0 1
s, 1H, s, s s, s, s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ,,).-(,-).,., 13 8 0 1 0 0 1
55.37, 109.88, 55.37, 5 55 55. 55.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .,.,.,.,.,.,., 14 8 0 1 0 0 1
128.21, 128.73, 128.21, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .,.,.,.,.,.,., 14 8 0 1 0 0 1
150.92, 161.03, 150.92, 1 15 150 150. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .,.,..-., 9 10 0 1 0 0 1
491.38; found: 491.38; 4 49 491 491. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .;:/.[].. 9 8 0 1 0 0 1
C 25 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 0 :.,.,..:., 10 10 0 1 0 0 1
H 4.71, h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 0 .,.. 4 2 0 1 0 0 1
N-(4-Bromophenyl)-2-[5-(3-methoxyphenylamino)- N-(4-Bromophenyl)-2-[5-(3-methoxyphenylamino)- n-(4-bromophenyl)-2-[5-(3-methoxyphenylamino)- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 -(-)--[-(-)- 12 10 0 0 0 0 1
pyrazol-1-yl]acetamide, 4e pyrazol-1-yl]acetamide, p py pyr pyra BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 --], 4 5 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 ;-();-(, 8 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 -).(,,),.(,,),. 15 9 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 (,.,,),.(,.,, 13 8 0 0 0 0 1
Ar), 6.41 ar), A Ar Ar) Ar), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 ),.(,,),.(,.,,),. 17 8 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 (,.,,),.(,.,,), 15 9 0 0 0 0 1
7.47 (d, 7.47 7 7. 7.4 7.47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .(,.,,),.(,.,,), 16 9 0 0 0 0 1
7.89 (exch 7.89 7 7. 7.8 7.89 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .(,,),.(,,).- 13 8 0 0 0 0 1
NMR (100 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 (,-).,.,.,., 12 8 0 0 0 0 1
104.21, 107.62, 104.21, 1 10 104 104. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .,.,.,.,.,.,., 14 8 0 0 0 0 1
139.32, 147.70, 139.32, 1 13 139 139. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .,.,.,.,..-. 12 8 0 0 0 0 1
C 18 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 1 ,.;:/.[].. 10 10 0 0 0 0 1
Calcd for calcd C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 :.,.,..: 8 9 0 0 0 0 1
C 53.70, c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 1 .,.,.. 6 3 0 0 0 0 1
2.2.3 | 2.2.3 2 2. 2.2 2.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .., 3 10 0 0 0 0 1
To a to T To To To BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 (.,;.) 6 9 0 0 0 0 1
in EtOH in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 3 (),., 5 8 0 0 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ., 2 10 0 0 0 0 1
evaporated under evaporated e ev eva evap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ,-(), 5 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (). 3 9 0 0 0 0 1
The organic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 9 0 0 0 0 1
under vacuum. under u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 . 1 9 0 0 0 0 1
pure after pure p pu pur pure BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 . 1 6 0 0 0 0 1
3-(3-Methoxyphenyl)-5-methyl-1H-pyrazole-4- 3-(3-Methoxyphenyl)-5-methyl-1H-pyrazole-4- 3-(3-methoxyphenyl)-5-methyl-1h-pyrazole-4- 3 3- 3-( 3-(3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 -(-)------ 10 10 0 0 0 0 1
carbonitrile, 6a carbonitrile, c ca car carb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 , 1 3 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 ;-();-(, 8 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 ).(,,);.(,,);.(, 16 9 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 4 .,,);.(,,);.(,,);. 18 9 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 (,,).-.,.;: 11 9 0 0 0 0 1
m/z 214.03 m/z m m/ m/z m/z BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 /.[]..:., 9 10 0 0 0 0 1
H 5.20, h H H H H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 4 .,..:.,.,.. 11 7 0 0 0 0 1
3-(4-Methoxyphenyl)-5-methyl-1H-pyrazole-4- 3-(4-Methoxyphenyl)-5-methyl-1H-pyrazole-4- 3-(4-methoxyphenyl)-5-methyl-1h-pyrazole-4- 3 3- 3-( 3-(4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 -(-)------ 10 10 0 0 0 0 1
carbonitrile, 6b carbonitrile, c ca car carb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 , 1 3 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 ;-();-(, 8 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 ).(,,);.(,,);.(, 16 9 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 .,,);.(,.,,).- 14 8 0 0 0 0 1
calcd. for calcd. c ca cal calc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 .,.;:/.[]. 10 10 0 0 0 0 1
Anal. Calcd anal. A An Ana Anal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 .:.,.,.. 8 10 0 1 0 0 1
Found: C found: F Fo Fou Foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 :.,.,.. 7 5 0 1 0 0 1
2.2.4 | 2.2.4 2 2. 2.2 2.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 .., 3 10 0 1 0 0 1
Compounds 7a,b compounds C Co Com Comp BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 ,- 2 10 0 1 0 0 1
lowing the lowing l lo low lowi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 -.- 3 9 0 1 0 0 1
pounds were pounds p po pou poun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 6 . 1 8 0 1 0 0 1
N-(4-Bromophenyl)-2-[4-cyano-3-(3-methoxyphenyl)-5- N-(4-Bromophenyl)-2-[4-cyano-3-(3-methoxyphenyl)-5- n-(4-bromophenyl)-2-[4-cyano-3-(3-methoxyphenyl)-5- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 -(-)--[---(-)-- 15 10 0 0 0 0 1
methylpyrazol-1-yl]acetamide, 7a methylpyrazol-1-yl]acetamide, m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 --], 4 6 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 ;-();-(, 8 7 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 -).(,,);.(,,);.(, 17 9 0 0 0 0 1
2H, CH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 ,);.(,,);.(,,);.(, 18 9 0 0 0 0 1
2H, Ar); 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 ,);.(,,).-(,-) 14 8 0 0 0 0 1
δ 10.92; δ δ δ δ δ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 7 .;.;.;.;.;.;.;.; 16 9 0 0 0 0 1
121.71; 130.68; 121.71; 1 12 121 121. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .;.;.;.;.;.;.; 14 8 0 0 0 0 1
160.01; 164.99. 160.01; 1 16 160 160. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 .;..-.,.; 9 9 0 0 0 0 1
found: m/z found: f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 :/.[]..: 8 10 0 0 0 0 1
C 56.48, c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 7 .,.,..:.,.,.. 13 8 0 0 0 0 1
N-(4-Bromophenyl)-2-[4-cyano-3-(4-methoxyphenyl)-5- N-(4-Bromophenyl)-2-[4-cyano-3-(4-methoxyphenyl)-5- n-(4-bromophenyl)-2-[4-cyano-3-(4-methoxyphenyl)-5- N N- N-( N-(4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 -(-)--[---(-)-- 15 10 0 0 0 0 1
methylpyrazol-1-yl]acetamide, 7b methylpyrazol-1-yl]acetamide, m me met meth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 --], 4 6 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 ;-();-(, 8 7 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 -).(,,);.(,,);.(, 17 9 0 0 0 0 1
2H, CH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 ,);.(,.,,);.(,,);. 18 9 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (,.,,);.(,,);- 14 8 0 0 0 0 1
(DMSO-d 6 (dmso-d ( (D (DM (DMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (-).;.;.;.;.;.; 15 8 0 0 0 0 1
121.72; 123.59; 121.72; 1 12 121 121. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .;.;.;.;.;.;.; 14 8 0 0 0 0 1
160.47; 165.05. 160.47; 1 16 160 160. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 .;..-.,.; 9 9 0 0 0 0 1
found: m/z found: f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 :/.[]..: 8 10 0 0 0 0 1
C 56.48, c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 .,.,..:.,.,.. 13 8 0 0 0 0 1
2.2.5 | 2.2.5 2 2. 2.2 2.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 .., 3 10 0 0 0 0 1
Compounds 9a,b compounds C Co Com Comp BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 ,- 2 9 0 0 0 0 1
ate substrate ate a at ate ate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 (,- 3 10 0 0 0 0 1
viously reported viously v vi vio viou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 (',) 4 9 0 0 0 0 1
same procedure same s sa sam same BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 -. 2 9 0 0 0 0 1
purified by purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 9 0 0 0 0 1
cyclohexane/ethyl acetate cyclohexane/ethyl c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 /:/ 3 10 0 0 0 0 1
acetate 1:3 acetate a ac ace acet BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 :. 2 3 0 0 0 0 1
N-(4-Bromophenyl)-2-(5-oxo-2-phenyl-2,5- N-(4-Bromophenyl)-2-(5-oxo-2-phenyl-2,5- n-(4-bromophenyl)-2-(5-oxo-2-phenyl-2,5- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -(-)--(----,- 13 10 0 0 0 0 1
dihydropyrazol-1-yl)acetamide, 9a dihydropyrazol-1-yl)acetamide, d di dih dihy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 --), 4 8 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 ;-();-(, 8 8 0 0 1 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 -).(,,);.(,.,, 14 9 0 0 0 0 1
pyrazolone); 7.19 pyrazolone); p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 );.(,.,,);.(,., 15 10 0 0 0 0 1
2H, Ar); 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 ,);.(,.,,);.(,., 16 9 0 0 0 0 1
2H, Ar); 2h, 2 2H 2H, 2H, BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 ,);.(,.,,);.(,., 16 9 0 0 0 0 1
| 587 | | | | | BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 10 0 1 1 0 1
1H, pyrazolone,); 1h, 1 1H 1H, 1H, BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ,,);.(,,).- 11 8 0 1 0 0 1
(100 MHz, (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (,-).;.;.;.; 12 8 0 1 0 0 1
119.01; 123.11; 119.01; 1 11 119 119. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .;.;.;.;.;.;.; 14 8 0 1 0 0 1
169.01. ESI-MS 169.01. 1 16 169 169. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ..-.,.;: 8 10 0 1 0 0 1
m/z 372.94 m/z m m/ m/z m/z BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 /.[]..: 7 10 0 1 0 0 1
54.86, H 54.86, 5 54 54. 54.8 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 .,.,..:.,.,.. 13 9 0 1 0 0 1
2-(4-Amino-5-oxo-2-phenyl-2,5-dihydropyrazol-1-yl)-N- 2-(4-Amino-5-oxo-2-phenyl-2,5-dihydropyrazol-1-yl)-N- 2-(4-amino-5-oxo-2-phenyl-2,5-dihydropyrazol-1-yl)-n- 2 2- 2-( 2-(4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 -(------,---)-- 15 10 0 1 0 0 1
(4-bromophenyl)acetamide, 9b (4-bromophenyl)acetamide, ( (4 (4- (4-b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (-), 4 5 0 1 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 ;-();-(, 8 7 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 -).(,,);.(,,); 14 9 0 0 0 0 1
7.04 (t, 7.04 7 7. 7.0 7.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 .(,.,,);.(,.,,);. 17 9 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 (,,);.(,:,;,);.( 16 8 0 0 0 0 1
br s, br b br br br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 ,,).-.,.; 9 9 0 0 0 0 1
found: m/z found: f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 :/.[]..: 8 10 0 0 0 0 1
C 52.73, c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 1 .,.,..:.,.,.. 13 8 0 0 0 0 1
N-(4-Bromophenyl)-2-[4-(3-methoxyphenylamino)-5-oxo- N-(4-Bromophenyl)-2-[4-(3-methoxyphenylamino)-5-oxo- n-(4-bromophenyl)-2-[4-(3-methoxyphenylamino)-5-oxo- N N- N-( N-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 -(-)--[-(-)--- 14 10 0 0 0 0 1
2-phenyl-2,5-dihydropyrazol-1-yl]acetamide, 10 2-phenyl-2,5-dihydropyrazol-1-yl]acetamide, 2 2- 2-p 2-ph BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 --,---], 8 9 0 0 0 0 1
Compound 10 compound C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 0 0 0 0 1
same procedure same s sa sam same BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 -.- 3 8 0 0 0 0 1
pound was pound p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 0 0 0 0 1
toluene/methanol 9:1 toluene/methanol t to tol tolu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 /:. 3 4 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ;-();- 6 6 0 0 0 0 1
(400 MHz, (400 ( (4 (40 (400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 (,-).(,,);.(,, 14 8 0 0 0 0 1
NCH 2 nch N NC NCH NCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 );.(,,);.(,,);.(,., 19 9 0 0 0 0 1
1H, Ar); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 ,);.(,.,,);.(,.,,); 19 10 0 0 0 0 1
7.39 (m, 7.39 7 7. 7.3 7.39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 .(,:,;,,);.(,.,, 16 9 0 0 0 0 1
Ar); 7.58 ar); A Ar Ar) Ar); BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 );.(,.,,);.(,.,,); 18 9 0 0 0 0 1
8.32 (s, 8.32 8 8. 8.3 8.32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 .(,,);.(,,).- 13 8 0 0 0 0 1
(100 MHz, (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 (,-).;.;.;.;.; 14 8 0 0 0 0 1
112.60; 115.67; 112.60; 1 11 112 112. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 .;.;.;.;.;.;.; 14 8 0 0 0 0 1
130.20; 132.11; 130.20; 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 .;.;.;.;.;.;.; 14 8 0 0 0 0 1
166.96. ESI-MS 166.96. 1 16 166 166. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 ..-.,.;:/ 9 9 0 0 0 0 1
494.11 [M 494.11 4 49 494 494. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 .[]..:., 8 9 0 0 0 0 1
4.29, N 4.29, 4 4. 4.2 4.29 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 2 .,..:.,.,.. 11 6 0 0 0 0 1
2.2.6 | 2.2.6 2 2. 2.2 2.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 ..- 3 10 0 0 0 0 1
To a to T To To To BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 (',;.) 6 9 0 0 0 0 1
and K and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 (.)., 5 8 0 0 0 0 1
0.63 mmol 0.63 0 0. 0.6 0.63 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 ., 2 9 0 0 0 0 1
the mixture the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 .,- 3 9 0 0 0 0 1
water was water w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 (), 3 9 0 0 0 0 1
with CH with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 (). 3 10 0 0 0 0 1
Na 2 na N Na Na Na BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 4 .- 2 9 0 0 0 0 1
were purified were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 8 0 0 0 0 1
clohexane/ethyl acetate clohexane/ethyl c cl clo cloh BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 /:. 3 6 0 0 0 0 1
4-Bromo-1-phenyl-2-n.propyl-1,2-dihydropyrazol-3-one, 4-Bromo-1-phenyl-2-n.propyl-1,2-dihydropyrazol-3-one, 4-bromo-1-phenyl-2-n.propyl-1,2-dihydropyrazol-3-one, 4 4- 4-B 4-Br BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 -----.-,---, 12 10 0 0 0 0 1
12a 12a 12a 1 12 12a 12a BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 no 0 0 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 ;;-(,). 7 9 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (,.,,());.-.(,, 15 10 0 0 0 0 1
NCH 2 nch N NC NCH NCH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 );.(,.,,); 10 9 0 1 0 0 1
7.43 (m, 7.43 7 7. 7.4 7.43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 .(,,);.(,,);.(,,). 18 9 0 1 0 0 1
ESI-MS calcd. esi-ms E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 -.,.;:/. 8 9 0 1 0 0 1
[M + [m [ [M [M [M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 []..:.,., 9 10 0 1 0 0 1
9.96. Found: 9.96. 9 9. 9.9 9.96 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ..:.,.,.. 9 5 0 1 0 0 1
4-Bromo-2-n.butyl-1-phenyl-1,2-dihydropyrazol-3-one, 4-Bromo-2-n.butyl-1-phenyl-1,2-dihydropyrazol-3-one, 4-bromo-2-n.butyl-1-phenyl-1,2-dihydropyrazol-3-one, 4 4- 4-B 4-Br BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ---.---,---, 12 10 0 1 0 0 1
12b 12b 12b 1 12 12b 12b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 no 0 0 0 1 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 ;;-(,).(, 9 8 0 0 0 0 1
3H, N(CH 3h, 3 3H 3H, 3H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 ,());.(,,());.(, 16 10 0 0 0 0 1
2H, NCH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 ,);.(,,()); 11 9 0 0 0 0 1
7.42 (m, 7.42 7 7. 7.4 7.42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 .(,,);.(,,);.(,,). 18 8 0 0 0 0 1
ESI-MS calcd. esi-ms E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 -.,.;:/. 8 9 0 0 0 0 1
[M + [m [ [M [M [M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 []..:.,., 9 9 0 0 0 0 1
9.49. Found: 9.49. 9 9. 9.4 9.49 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 ..:.,.,.. 9 5 0 0 0 0 1
4-Bromo-2-n.hexyl-1-phenyl-1,2-dihydropyrazol-3-one, 4-Bromo-2-n.hexyl-1-phenyl-1,2-dihydropyrazol-3-one, 4-bromo-2-n.hexyl-1-phenyl-1,2-dihydropyrazol-3-one, 4 4- 4-B 4-Br BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 ---.---,---, 12 10 0 0 0 0 1
12c 12c 12c 1 12 12c 12c BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 0 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ;;-(,).(, 9 8 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 .,,());.(,,() 13 9 0 0 0 0 1
CH 2 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 );.(,,()());.- 14 10 0 0 0 0 1
1.84 (m, 1.84 1 1. 1.8 1.84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 .(,,());.(,., 13 9 0 0 0 0 1
2H, NCH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 ,());.(,.,,);. 14 9 0 0 0 0 1
(m, 3H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 (,,);.(,,).-. 13 8 0 0 0 0 1
C 15 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 ,.;:/.[].. 10 9 0 0 0 0 1
Calcd for calcd C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 :.,.,..: 8 9 0 0 0 0 1
55.92, H 55.92, 5 55 55. 55.9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 .,.,.. 6 3 0 0 0 0 1
2.2.7 | 2.2.7 2 2. 2.2 2.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ..- 3 10 0 0 0 0 1
To a to T To To To BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 (-; 3 9 0 0 0 0 1
0.43 mmol) 0.43 0 0. 0.4 0.43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 .).() 5 9 0 0 0 0 1
palladium(0) in palladium(0) p pa pal pall BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ()(), 5 9 0 0 0 0 1
appropriate arylboronic appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 (.-.) 5 9 0 0 0 0 1
(1-3 ml) (1-3 ( (1 (1- (1-3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (-)..- 6 9 0 0 0 0 1
ture was ture t tu tur ture BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 -- 2 9 0 0 0 0 1
pounds 13a pounds p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 9 , 1 8 0 0 0 0 1
for 6-12 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 -,,,. 5 9 0 0 0 0 1
solvent under solvent s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ,-(-) 5 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 (). 3 9 0 0 0 0 1
compound 13c, compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 , 1 8 0 0 0 0 1
6N HCl 6n 6 6N 6N 6N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (). 3 9 0 0 0 0 1
Finally, the finally, F Fi Fin Fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 ,- 2 9 0 0 0 0 1
rated in rated r ra rat rate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
flash chromatography flash f fl fla flas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 / 1 9 0 0 0 0 1
7:0.2 for 7:0.2 7 7: 7:0 7:0. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 :.,/:, 6 9 0 0 0 0 1
CH 2 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 /:,/:. 6 10 0 0 0 0 1
13d, and 13d, 1 13 13d 13d, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ,/:.. 5 7 0 0 0 0 1
4-(3-Methoxyphenyl)-1-phenyl-2-n.propyl-1,2- 4-(3-Methoxyphenyl)-1-phenyl-2-n.propyl-1,2- 4-(3-methoxyphenyl)-1-phenyl-2-n.propyl-1,2- 4 4- 4-( 4-(3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 -(-)----.-,- 12 10 0 0 0 0 1
dihydropyrazol-3-one, 13a dihydropyrazol-3-one, d di dih dihy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 --, 3 5 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 ;;-(,). 7 9 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 (,.,,());.-.(,, 15 10 0 0 0 0 1
588 | 588 5 58 588 588 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 10 0 1 1 0 1
NCH 2 nch N NC NCH NCH BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 );.(,,);.(,.,, 14 10 0 1 0 0 1
NCH 2 nch N NC NCH NCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 );.(,.,,);.(,, 14 9 0 1 0 0 1
Ar); 7.17 ar); A Ar Ar) Ar); BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 );.(,.,,);.(,.,,); 18 9 0 1 0 0 1
7.52 (s, 7.52 7 7. 7.5 7.52 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .(,,);.(,,);.(,,). 18 9 0 1 0 0 1
13 C-NMR 13 1 13 13 13 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 -(,).;.;.;.; 12 8 0 1 0 0 1
112.68; 117.81; 112.68; 1 11 112 112. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .;.;.;.;.;.;.; 14 8 0 1 0 0 1
132.34; 138.40; 132.34; 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .;.;.;.;.;..- 13 7 0 1 0 0 1
calcd. for calcd. c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 .,.;:/.[]. 10 10 0 1 0 0 1
Anal. Calcd anal. A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 .:.,.,..: 9 9 0 1 0 0 1
C 74.25, c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 .,.,.. 6 3 0 1 0 0 1
4-(3,4-Dimethoxyphenyl)-1-phenyl-2-n.propyl-1,2- 4-(3,4-Dimethoxyphenyl)-1-phenyl-2-n.propyl-1,2- 4-(3,4-dimethoxyphenyl)-1-phenyl-2-n.propyl-1,2- 4 4- 4-( 4-(3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 -(,-)----.-,- 13 10 0 0 0 0 1
dihydropyrazol-3-one, 13b dihydropyrazol-3-one, d di dih dihy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 --, 3 5 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 ;;-(,). 7 8 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 1 (,.,,());.-.(,, 15 8 0 0 0 0 1
NCH 2 nch N NC NCH NCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 1 );.(,,);.(,,); 14 9 0 0 0 0 1
4.30 (t, 4.30 4 4. 4.3 4.30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 .(,.,,);.(,., 13 10 0 0 0 0 1
1H, Ar); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 ,);.(,,);.(,.,, 15 9 0 0 0 0 1
1H, Ar); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 ,);.-.(,,);.(,,). 17 8 0 0 0 0 1
13 C-NMR 13 1 13 13 13 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 1 -(,).;.;.; 10 7 0 0 0 0 1
71.32; 110.22; 71.32; 7 71 71. 71.3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 .;.;.;.;.;.;.; 14 8 0 0 0 0 1
137.73; 138.47; 137.73; 1 13 137 137. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 .;.;.;.;..-. 12 9 0 0 0 0 1
C 20 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 2 ,.;:/.[].. 10 10 0 0 0 0 1
Calcd for calcd C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 2 :.,.,..: 8 10 0 0 0 0 1
70.78, H 70.78, 7 70 70. 70.7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 .,.,.. 6 3 0 0 0 0 1
4-(4-Hydroxyphenyl)-1-phenyl-2-n.propyl-1,2- 4-(4-Hydroxyphenyl)-1-phenyl-2-n.propyl-1,2- 4-(4-hydroxyphenyl)-1-phenyl-2-n.propyl-1,2- 4 4- 4-( 4-(4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 -(-)----.-,- 12 10 0 0 0 0 1
dihydropyrazol-3-one, 13c dihydropyrazol-3-one, d di dih dihy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 --, 3 5 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 3 ;;-(,). 7 7 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (,.,,());.-.(,, 15 8 0 0 0 0 1
NCH 2 nch N NC NCH NCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 );.(,.,,);. 11 10 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 (,.,,);.(,.,,);.(, 18 9 0 0 0 0 1
4H, Ar); 4h, 4 4H 4H, 4H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ,);.(,,);.(,,).- 16 9 0 0 0 0 1
(100 MHz, (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 (,).;.;.;.;.; 13 8 0 0 0 0 1
123.90; 125.13; 123.90; 1 12 123 123. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .;.;.;.;.;.;.; 14 8 0 0 0 0 1
157.74; 164.12. 157.74; 1 15 157 157. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .;..-.,.; 9 9 0 0 0 0 1
found: m/z found: f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 :/.[]..: 8 10 0 0 0 0 1
73.45, H 73.45, 7 73 73. 73.4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .,.,..:.,.,.. 13 8 0 0 0 0 1
Butyl-4-(3-methoxyphenyl)-1-phenyl-1,2-dihydropyrazol- Butyl-4-(3-methoxyphenyl)-1-phenyl-1,2-dihydropyrazol- butyl-4-(3-methoxyphenyl)-1-phenyl-1,2-dihydropyrazol- B Bu But Buty BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 --(-)---,-- 11 10 0 0 0 0 1
3-one, 13d 3-one, 3 3- 3-o 3-on BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 -, 2 2 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 ;;-(,). 7 7 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 (,.,,);.(,, 11 8 0 0 0 0 1
NCH 2 nch N NC NCH NCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 );.(,,);.(, 11 10 0 0 0 0 1
3H, OCH 3h, 3 3H 3H, 3H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 ,);.(,.,,);. 12 9 0 0 0 0 1
(d, J (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 (,.,,);.(,,);.(,., 18 9 0 0 0 0 1
1H, Ar); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 ,);.(,.,,);.(,,);. 18 8 0 0 0 0 1
(s, 4H, (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 (,,);.(,,).-(, 14 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ).;.;.;.;.;.;.; 15 8 0 0 0 0 1
119.00; 127.52; 119.00; 1 11 119 119. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 .;.;.;.;.;.;.; 14 8 0 0 0 0 1
160.02; 160.96. 160.02; 1 16 160 160. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 .;..-.,.; 9 8 0 0 0 0 1
found: m/z found: f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 :/.[]..: 8 9 0 0 0 0 1
74.51, H 74.51, 7 74 74. 74.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 .,.,..:.,.,.. 13 7 0 0 0 0 1
Butyl-4-(3,4-dimethoxyphenyl)-1-phenyl-1,2- Butyl-4-(3,4-dimethoxyphenyl)-1-phenyl-1,2- butyl-4-(3,4-dimethoxyphenyl)-1-phenyl-1,2- B Bu But Buty BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 --(,-)---,- 11 10 0 1 0 0 1
dihydropyrazol-3-one, 13e dihydropyrazol-3-one, d di dih dihy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 --, 3 6 0 1 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 ;;-(,).(, 9 8 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 6 .,,);.-.(,, 11 8 0 1 0 0 1
NCH 2 nch N NC NCH NCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 );.-.(,,); 10 9 0 1 0 0 1
3.92 (s, 3.92 3 3. 3.9 3.92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .(,,);.(,,);.(,., 17 10 0 1 0 0 1
2H, NCH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 ,);.(,.,,,); 12 8 0 1 0 0 1
7.09 (s, 7.09 7 7. 7.0 7.09 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .(,,);.(,.,,);.(, 17 8 0 1 0 0 1
1H, Ar); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 ,);.(,,);.(,,).- 16 8 0 1 0 0 1
NMR (100 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 (,).;.;.;.; 11 7 0 1 0 0 1
69.48; 110.75; 69.48; 6 69 69. 69.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .;.;.;.;.;.;.; 14 8 0 1 0 0 1
137.77; 138.47; 137.77; 1 13 137 137. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .;.;.;.;..-. 12 8 0 1 0 0 1
C 21 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 6 ,.;:/.[].. 10 9 0 1 0 0 1
Calcd for calcd C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 :.,.,..: 8 9 0 1 0 0 1
71.39, H 71.39, 7 71 71. 71.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 .,.,.. 6 3 0 1 0 0 1
Hexyl-4-(3-methoxyphenyl)-1-phenyl-1,2-dihydropyrazol- Hexyl-4-(3-methoxyphenyl)-1-phenyl-1,2-dihydropyrazol- hexyl-4-(3-methoxyphenyl)-1-phenyl-1,2-dihydropyrazol- H He Hex Hexy BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 --(-)---,-- 11 10 0 0 0 0 1
3-one, 13f 3-one, 3 3- 3-o 3-on BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 -, 2 2 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 ;;-(,).(, 9 8 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 8 ,,());.(,,() 12 9 0 0 0 0 1
H 2 h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 8 );.(,,()());.-. 15 10 0 0 0 0 1
(m, 2H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (,,());.(,,);. 14 9 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (,.,,());.(,., 14 9 0 0 0 0 1
1H, Ar); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 ,);.(,,);.(,,,);. 17 8 0 0 0 0 1
(t, J (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (,.,,);.(,,);.(,,- 18 8 0 0 0 0 1
zolone). 13 zolone). z zo zol zolo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 ).-(,).;.;.; 12 8 0 0 0 0 1
29.03; 31.56; 29.03; 2 29 29. 29.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .;.;.;.;.;.;.;.; 16 8 0 0 0 0 1
128.10; 131.91; 128.10; 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .;.;.;.;.;.;.. 14 8 0 0 0 0 1
ESI-MS calcd. esi-ms E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 -.,.;:/. 8 9 0 0 0 0 1
[M + [m [ [M [M [M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 []..:.,., 9 9 0 0 0 0 1
7.99. Found: 7.99. 7 7. 7.9 7.99 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 ..:.,.,.. 9 5 0 0 0 0 1
2.2.8 | 2.2.8 2 2. 2.2 2.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 .. 2 10 0 0 0 0 1
Compounds 15 compounds C Co Com Comp BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 no 0 9 0 0 0 0 1
from commercially from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ,- 2 9 0 0 0 0 1
dure described dure d du dur dure BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 -.- 3 9 0 0 0 0 1
umn flash umn u um umn umn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 / 1 10 0 0 0 0 1
acetate 1:3, acetate a ac ace acet BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 :,. 3 8 0 0 0 0 1
N-(4-bromophenyl)-2-[(5-methyl-1H-pyrazol-3-yl)oxy] N-(4-bromophenyl)-2-[(5-methyl-1H-pyrazol-3-yl)oxy] n-(4-bromophenyl)-2-[(5-methyl-1h-pyrazol-3-yl)oxy] N N- N-( N-(4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 -(-)--[(-----)] 15 10 0 0 0 0 1
acetamide, 15 acetamide, a ac ace acet BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 , 1 2 0 0 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 ;-();-(, 8 7 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 -).(,,);.(,,);. 15 9 0 0 0 0 1
(s, 1H, (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 (,,);.(,.,,);.(, 16 9 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 .,,);.(,,);. 12 8 0 0 0 0 1
(exch br (exch ( (e (ex (exc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 (,,).-(-) 9 8 0 0 0 0 1
11.43, 67.57, 11.43, 1 11 11. 11.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 .,.,.,.,.,.,., 14 8 0 0 0 0 1
140.50, 162.50, 140.50, 1 14 140 140. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 .,.,..-., 9 10 0 0 0 0 1
310.15; found: 310.15; 3 31 310 310. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 .;:/.[].. 9 8 0 0 0 0 1
C 12 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 :.,.,..:., 10 10 0 0 0 0 1
H 3.89, h H H H H BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 10 .,.. 4 2 0 0 0 0 1
| 589 | | | | | BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 10 0 1 1 0 1
N-(4-bromophenyl)-2-{3-[2-(4-bromophenyl)amino]-2- N-(4-bromophenyl)-2-{3-[2-(4-bromophenyl)amino]-2- n-(4-bromophenyl)-2-{3-[2-(4-bromophenyl)amino]-2- N N- N-( N-(4 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 1 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -(-)---[-(-)]-- 15 10 0 1 0 0 1
oxoethoxy}-5-methyl-1H-pyrazol-1-yl)acetamide, 16 oxoethoxy}-5-methyl-1h-pyrazol-1-yl)acetamide, o ox oxo oxoe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ------), 8 10 0 1 0 0 1
Yield = yield Y Yi Yie Yiel BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ;-();-(, 8 6 0 1 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 -).(,,);.(,,);.(, 17 9 0 1 0 0 1
2H, NCH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ,);.(,,);.(,,);. 16 8 0 1 0 0 1
(exch br (exch ( (e (ex (exc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,,);.(,,).- 12 8 0 1 0 0 1
(100 MHz (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (-).,.,.,.,., 13 8 0 1 0 0 1
121.59, 121.94, 121.59, 1 12 121 121. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.,., 14 7 0 1 0 0 1
166.32, 167.29. 166.32, 1 16 166 166. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,..-.,.; 9 9 0 1 0 0 1
found: m/z found: f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :/.[]..: 8 10 0 1 0 0 1
C, 56.48; c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,.;,,;,,.:,.,,.,, 17 8 0 1 0 0 1
13.15. 13.15. 13.15. 1 13 13. 13.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .. 2 0 0 1 0 0 1
2.3 | 2.3 2 2. 2.3 2.3 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 . 1 10 0 0 0 0 1
2.3.1 | 2.3.1 2 2. 2.3 2.3. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 .. 2 10 0 0 0 0 1
Human promyelocytic human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 - 1 8 0 0 0 0 1
fected with fected f fe fec fect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 (-)(- 5 8 0 0 0 0 1
cells; kind cells; c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ;.-, 4 9 0 0 0 0 1
Joseph Fourier, joseph J Jo Jos Jose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 2 ,,) 3 9 0 0 0 0 1
1640 medium 1640 1 16 164 1640 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 5 2 - 1 9 0 0 0 0 1
calf serum, calf c ca cal calf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ,,/,/ 5 9 0 0 0 0 1
ml penicillin, ml m ml ml ml BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 ,(/). 5 10 0 0 0 0 1
are cultured are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 9 0 0 0 0 1
some assays, some s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 , 1 9 0 0 0 0 1
before assays before b be bef befo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 . 1 4 0 0 0 0 1
2.3.2 | 2.3.2 2 2. 2.3 2.3. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .. 2 10 0 0 0 0 1
Blood was blood B Bl Blo Bloo BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 0 0 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 0 0 0 0 1
at Montana at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 . 1 9 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 , 1 9 0 0 0 0 1
Histopaque 1077 histopaque H Hi His Hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 no 0 9 0 0 0 0 1
red blood red r re red red BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 . 1 10 0 0 0 0 1
resuspended in resuspended r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 -.- 3 9 0 0 0 0 1
tinely >95% tinely t ti tin tine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ,, 2 9 0 0 0 0 1
>98% viable, >98% > >9 >98 >98% BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 ,. 2 8 0 0 0 0 1
2.3.3 | 2.3.3 2 2. 2.3 2.3. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .. 2 10 0 0 0 0 1
Changes in changes C Ch Cha Chan BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
FlexStation II flexstation F Fl Fle Flex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 (). 3 9 0 0 0 0 1
The cells, the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 ,'- 3 9 0 0 0 0 1
out Ca out o ou out out BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (-), 4 9 0 0 0 0 1
loaded with loaded l lo loa load BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ./-.. 5 9 0 0 0 0 1
30 min 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 5 ., 2 10 0 0 0 0 1
washed with washed w wa was wash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -, 2 8 0 0 0 0 1
in HBSS in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 ,, 2 8 0 0 0 0 1
(HBSS + (hbss ( (H (HB (HBS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 (),-,- 6 9 0 1 0 0 1
area-well black area-well a ar are area BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 -(/). 5 9 0 1 0 0 1
evaluation of evaluation e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 9 0 1 0 0 1
were added were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 no 0 9 0 1 0 0 1
compounds in compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 8 0 1 0 0 1
monitored (λ monitored m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (,) 3 9 0 1 0 0 1
at room at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 . 1 9 0 1 0 0 1
Maximum change maximum M Ma Max Maxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 ,- 2 9 0 1 0 0 1
pressed in pressed p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 , 1 10 0 1 0 0 1
a response. a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 5 6 . 1 9 0 1 0 0 1
the response the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 - 1 8 0 1 0 0 1
and neutrophils, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ,-, 3 8 0 1 0 0 1
which were which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 .(- 3 8 0 1 0 0 1
points) and points) p po poi poin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 )- 2 9 0 1 0 0 1
centrations (IC centrations c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 () 2 9 0 1 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 - 1 9 0 1 0 0 1
7 (GraphPad 7 7 7 7 7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 6 (,.). 5 4 0 1 0 0 1
2.4 | 2.4 2 2. 2.4 2.4 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 .-- 3 10 0 0 0 0 1
(SCXRD) (SCXRD) (scxrd) ( (S (SC (SCX BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 () 2 10 0 0 0 0 1
Intensity data intensity I In Int Inte BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
using a using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -. 2 8 0 0 0 0 1
collected with collected c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (,) 3 9 0 0 0 0 1
and integrated and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
(Bruker, 2012b); (bruker, ( (B (Br (Bru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 (,); 4 9 0 0 0 0 1
SADABS-2016/2 (Krause sadabs-2016/2 S SA SAD SADA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 8 -/(.,). 7 9 0 0 0 0 1
was Cu-Kα was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -(.). 5 8 0 0 0 0 1
solved using solved s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -(,) 4 8 0 0 0 0 1
and refined and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 - 1 10 0 0 0 0 1
all data all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (-/(,).- 8 8 0 0 0 0 1
hydrogen atoms hydrogen h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 - 1 9 0 0 0 0 1
ment parameters, ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 , 1 8 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 8 .- 2 10 0 0 0 0 1
refined while refined r re ref refi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 - 1 9 0 0 0 0 1
ance with ance a an anc ance BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 . 1 8 0 0 0 0 1
Geometrical calculations geometrical G Ge Geo Geom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 8 0 0 0 0 1
(Nardelli, 1995) (nardelli, ( (N (Na (Nar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 (,) 3 9 0 0 0 0 1
the program the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (..;.,) 7 9 0 0 0 0 1
ORTEP-3 (Farrugia, ortep-3 O OR ORT ORTE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 -(,). 5 8 0 0 0 0 1
refinement parameters refinement r re ref refi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 ( 1 8 0 0 0 0 1
Supporting Information). supporting S Su Sup Supp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 ). 2 4 0 0 0 0 1
2.5 | 2.5 2 2. 2.5 2.5 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 . 1 10 0 0 0 0 1
Structures of structures S St Str Stru BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 ,,,,,, 6 9 0 0 0 0 1
were built were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 ,- 2 9 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 ,. 2 10 0 0 0 0 1
A homology a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 5 11 ( 1 8 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 .,)-- 5 9 0 0 0 0 1
with the with w wi wit with BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 ------- 7 9 0 0 0 0 1
590 | 590 5 59 590 590 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 10 0 1 1 0 1
(WKYMVm; Zhuang (wkymvm; ( (W (WK (WKY BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (;.,;) 6 7 0 0 0 0 1
taken as taken t ta tak take BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
study. Each study. s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
the Molegro the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .() 3 8 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,,,,,, 6 9 0 0 0 0 1
and 15. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
12 Å 12 1 12 12 12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
the bound the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ( 1 8 0 0 0 0 1
for FPR2). for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ). 2 8 0 0 0 0 1
0.3 Å 0.3 0 0. 0.3 0.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .. 2 9 0 0 0 0 1
with respect with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -. 2 9 0 0 0 0 1
structures were structures s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ."" 3 9 0 0 0 0 1
"sp 2 "sp " "s "sp "sp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 "-""- 5 10 0 0 0 0 1
uation" panel uation" u ua uat uati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ". 2 8 0 0 0 0 1
docking runs docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 8 0 0 0 0 1
pound with pound p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ." 2 9 0 0 0 0 1
for each for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ",- 3 9 0 0 0 0 1
"Energy minimization" "energy " "E "En "Ene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 """-"- 6 8 0 0 0 0 1
plied after plied p pl pli plie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
threshold of threshold t th thr thre BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 2 0 0 0 0 1
3 | 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 5 no 0 10 0 1 0 0 1
3.1 | 3.1 3 3. 3.1 3.1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 . 1 10 0 1 0 0 1
All new all A Al All All BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 7 0 0 0 0 1
Schemes 1-4, schemes S Sc Sch Sche BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 -,- 3 9 0 0 0 0 1
cal and cal c ca cal cal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 6 . 1 9 0 0 0 0 1
final pyrazole final f fi fin fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,- 2 9 0 0 0 0 1
tions 3, tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,,,,. 5 9 0 0 0 0 1
Compounds 4a-e compounds C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 - 1 9 0 0 0 0 1
commercially available commercially c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -, 2 9 0 0 0 0 1
with N-(4-bromophenyl)-2-chloroacetamide with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -(-)--(; 8 8 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 .,), 4 9 0 0 0 0 1
5-aminopyrazoles 3a-c. 5-aminopyrazoles 5 5- 5-a 5-am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 --., 4 9 0 0 0 0 1
3a-c and 3a-c 3 3a 3a- 3a-c BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ---, 4 8 0 0 0 0 1
with copper(II)acetate with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (), 3 10 0 0 0 0 1
final desired final f fi fin fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 5 0 0 0 0 1
For the for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 ,(),- 5 8 0 0 0 0 1
scribed isoxazolo-pyridazinones scribed s sc scr scri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -,(.,) 6 9 0 0 0 0 1
were transformed were w we wer were BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 - 1 8 0 0 0 0 1
S C s S S S S BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 10 : 1 8 0 1 1 1 1
(a) K (a) ( (a (a) (a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 (),,, 5 9 0 1 0 0 1
3-7 hr. 3-7 3 3- 3-7 3-7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 -.()-- 6 9 0 1 0 0 1
acid, (CH acid, a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 ,(),, 5 8 0 1 0 0 1
molecular sieves, molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 ,,, 3 10 0 1 0 0 1
2-26 hr 2-26 2 2- 2-2 2-26 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 - 1 1 0 1 0 0 1
| 591 | | | | | BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 10 0 1 1 0 1
S C s S S S S BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 : 1 9 0 1 0 0 1
(a) 2.5 (a) ( (a (a) (a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ().,,,.() 9 9 0 1 0 0 1
N-(4-bromophenyl)-2-chloroacetamide (2), n-(4-bromophenyl)-2-chloroacetamide N N- N-( N-(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 -(-)--(), 9 9 0 1 0 0 1
K 2 k K K K K BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 ,,, 3 10 0 1 0 0 1
S C s S S S S BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 3 : 1 8 0 0 1 0 1
(a) N-(4-bromophenyl)-2-chloroacetamide, (a) ( (a (a) (a) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 ()-(-)--, 9 8 0 0 0 0 1
K 2 k K K K K BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 3 ,,,-. 5 10 0 0 0 0 1
(b) For (b) ( (b (b) (b) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 ():- 4 7 0 0 0 0 1
acid, (CH acid, a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ,(),, 5 8 0 0 0 0 1
molecular sieves, molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ,, 2 7 0 0 0 0 1
rt, 3 rt, r rt rt, rt, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 ,.(),, 6 8 0 0 0 0 1
anhydrous DMF, anhydrous a an anh anhy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 ,,.() 5 7 0 0 0 0 1
Tetrakis(triphenylphosphine)palladium(0), Tetrakis(triphenylphosphine)palladium(0), tetrakis(triphenylphosphine)palladium(0), T Te Tet Tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 ()(), 5 9 0 0 0 0 1
arylboronic acid, arylboronic a ar ary aryl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 ,, 2 8 0 0 0 0 1
toluene, rt, toluene, t to tol tolu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 ,,-;, 5 9 0 0 0 0 1
and 13e,f, and a an and and BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ,,,- 4 5 0 0 0 0 1
592 | 592 5 59 592 592 BLOCKSTART PAGESTART SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 10 0 1 1 0 1
derivatives 6a,b derivatives d de der deri BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,. 2 9 0 1 0 0 1
in EtOH in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 no 0 8 0 1 0 0 1
same conditions same s sa sam same BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 6 0 1 0 0 1
In Scheme in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 no 0 8 0 1 0 0 1
the novel the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,,,-, 5 9 0 1 0 0 1
the 4-Br-phenylacetamide the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ---- 4 8 0 1 0 0 1
sition. Alkylation sition. s si sit siti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 9 0 1 0 0 1
(O'Brain & (o'brain ( (O (O' (O'B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (',)- 5 8 0 1 0 0 1
pound 9a pound p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 8 0 1 0 0 1
into the into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 0 1 0 0 1
3-methoxybenzeneboronic acid. 3-methoxybenzeneboronic 3 3- 3-m 3-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 -. 2 9 0 1 0 0 1
of type of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,-, 3 10 0 1 0 0 1
the starting the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (',)- 5 8 0 1 0 0 1
acted with acted a ac act acte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 1 0 0 1
tions, resulting tions, t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,-, 3 9 0 1 0 0 1
transformed into transformed t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 9 0 1 0 0 1
reaction with reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,()- 4 9 0 1 0 0 1
tetrakis triphenylphosphine tetrakis t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (),- 4 9 0 1 0 0 1
drous toluene. drous d dr dro drou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 2 0 1 0 0 1
Finally, when finally, F Fi Fin Fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 8 0 1 0 0 1
was reacted was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 1 0 0 1
the O-alkylated the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 9 0 1 0 0 1
16 was 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 ().- 4 9 0 1 0 0 1
derivative agrees derivative d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 0 1 0 0 1
forms reported forms f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 1 0 0 1
(Katritzky & (katritzky ( (K (Ka (Kat BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (,), 4 9 0 1 0 0 1
tautomers. Among tautomers. t ta tau taut BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 .,, 3 10 0 0 0 0 1
followed by followed f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 (.,;). 6 9 0 0 0 0 1
In order in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 3 no 0 9 0 0 0 0 1
15 and 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 3 , 1 9 0 0 0 0 1
resonance (NMR) resonance r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 ()(- 4 9 0 0 0 0 1
13 C-NMR) 13 1 13 13 13 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 3 -)(-- 5 9 0 0 0 0 1
HMBC) NMR hmbc) H HM HMB HMBC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 )( 2 8 0 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,-). 4 9 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (-) 3 10 0 0 0 0 1
compound 15 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (.) 3 8 0 0 0 0 1
shift value shift s sh shi shif BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 9 0 0 0 0 1
of type of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,,,,, 5 9 0 0 0 0 1
4.80 ppm. 4.80 4 4. 4.8 4.80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 ..- 3 9 0 0 0 0 1
pound 15 pound p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
the O-substituted the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 -. 2 9 0 0 0 0 1
with results with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
1 H-NMR 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 4 -. 2 9 0 0 0 0 1
δ = δ δ δ δ δ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 6 6 .,- 3 9 0 1 0 0 1
CH 2 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 -,. 3 5 0 1 0 0 1
Moving to moving M Mo Mov Movi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 -, 2 7 0 1 0 0 1
found that found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 8 0 1 0 0 1
4-Br-phenylacetamide chain 4-br-phenylacetamide 4 4- 4-B 4-Br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 --- 3 9 0 1 0 0 1
of type of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,,-.- 5 9 0 1 0 0 1
NMR analysis nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 . 1 9 0 1 0 0 1
present in present p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,, 2 9 0 1 0 0 1
while the while w wh whi whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 9 0 1 0 0 1
at δ at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ..., 4 8 0 1 0 0 1
compound 15, compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,- 2 8 0 1 0 0 1
eronuclear single eronuclear e er ero eron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ()- 3 8 0 1 0 0 1
nuclear multiple nuclear n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ()( 3 9 0 1 0 0 1
Supporting Information). supporting S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 )., 3 9 0 1 0 0 1
between the between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 8 0 1 0 0 1
assigned (Cα). assigned a as ass assi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ()., 4 8 0 1 0 0 1
with carbons with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 9 0 1 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 - 1 9 0 1 0 0 1
the N-1, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -, 2 9 0 1 0 0 1
and C5 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -. 2 9 0 1 0 0 1
On the on O On On On BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 9 0 1 0 0 1
the 4-bromophenylacetamide the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -- 2 8 0 1 0 0 1
the oxygen the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ., 2 9 0 1 0 0 1
nitrogen at nitrogen n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 10 0 1 0 0 1
a similar a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 6 6 ., 2 10 0 1 0 0 1
observe a observe o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 9 0 1 0 0 1
and CH and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ., 2 9 0 1 0 0 1
allow us allow a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 9 0 1 0 0 1
suggest a suggest s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -- 2 9 0 1 0 0 1
fold alkylation fold f fo fol fold BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (-), 4 9 0 1 0 0 1
according to according a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 8 0 1 0 0 1
in Figure in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 6 no 0 9 0 1 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -.- 3 9 0 1 0 0 1
crystal X-ray crystal c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 6 -,, 3 9 0 1 0 0 1
described below. described d de des desc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 2 0 1 0 0 1
S C s S S S S BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 11 :(), 4 10 0 1 0 0 1
CH 3 ch C CH CH CH BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 ,,- 3 3 0 1 0 0 1
| 593 | | | | | BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 10 0 1 1 0 1
3.2 | 3.2 3 3. 3.2 3.2 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .-- 3 10 0 1 0 0 1
crystal X-ray crystal c cr cry crys BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 -() 3 10 0 1 0 0 1
In order in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
pound 15, pound p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,, 2 8 0 0 0 0 1
the molecular the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 8 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 ,. 2 9 0 0 0 0 1
The choice the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
between the between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ( 1 8 0 0 0 0 1
Figure 3) figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 )- 2 9 0 0 0 0 1
gen atom gen g ge gen gen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
difference Fourier difference d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 9 0 0 0 0 1
Database (CSD, database D Da Dat Data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 (,..; 5 8 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .,) 3 9 0 0 0 0 1
Figure 3 figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
two containing two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ( 1 8 0 0 0 0 1
considered). Table considered). c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ). 2 10 0 0 0 0 1
atoms of atoms a at ato atom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
the CSD. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ., 2 9 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
reported above reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,, 2 9 0 0 0 0 1
pyrazole scaffold pyrazole p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 8 0 0 0 0 1
The overall the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 0 0 0 0 1
(see Figure (see ( (s (se (see BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (),. 4 9 0 0 0 0 1
(1)°. Considering (1)°. ( (1 (1) (1)° BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ().- 4 10 0 0 0 0 1
hydrogen atoms hydrogen h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 , 1 9 0 0 0 0 1
from planarity from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 (.()). 6 7 0 0 0 0 1
Finally, each finally, F Fi Fin Fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 ,- 2 8 0 0 0 0 1
termolecular H-bonds: termolecular t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 -:() 4 8 0 0 0 0 1
and 2 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 (). 3 9 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 4 ( 1 8 0 0 0 0 1
Figure S10). figure F Fi Fig Figu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 ). 2 2 0 0 0 0 1
3.3 | 3.3 3 3. 3.3 3.3 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 . 1 10 0 0 0 0 1
All new all A Al All All BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 - 1 10 0 0 0 0 1
tracellular Ca tracellular t tr tra trac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 () 2 10 0 0 0 0 1
HL-60 cells hl-60 H HL HL- HL-6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -, 2 10 0 0 0 0 1
reported as reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 9 0 0 0 0 1
compounds fMLF compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 (),(), 6 8 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ( 1 9 0 0 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 .,,).- 6 9 0 0 0 0 1
type non-transfected type t ty typ type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 --. 3 10 0 0 0 0 1
The new the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 8 0 0 0 0 1
both on both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 - 1 8 0 0 0 0 1
and on and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 - 1 8 0 0 0 0 1
stand whether stand s st sta stan BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 9 0 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 no 0 9 0 0 0 0 1
tautomer forms tautomer t ta tau taut BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 -- 2 10 0 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 . 1 9 1 0 0 0 1
Ellipsoid probability ellipsoid E El Ell Elli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 [ 1 10 1 0 0 0 1
wileyonlinelibrary.com] wileyonlinelibrary.com] wileyonlinelibrary.com] w wi wil wile BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 .] 2 4 1 0 0 0 1
T A t T T T T BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 - 1 10 1 0 0 0 1
rings of rings r ri rin ring BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 () 2 9 1 0 0 0 1
Bond Bond bond B Bo Bon Bond BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 9 no 0 10 1 0 0 0 1
Distance (Å) distance D Di Dis Dist BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 () 2 10 1 0 0 0 1
15 15 15 1 15 15 15 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 9 no 0 10 1 0 0 0 1
Tautomer C tautomer T Ta Tau Taut BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 no 0 6 1 0 0 0 1
min-max min-max min-max m mi min min- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 - 1 5 1 0 0 0 1
distance (mean) distance d di dis dist BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 () 2 10 1 0 0 0 1
Tautomer D tautomer T Ta Tau Taut BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 no 0 6 1 0 0 0 1
min-max distance min-max m mi min min- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 - 1 10 1 0 0 0 1
(mean) (mean) (mean) ( (m (me (mea BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 () 2 4 1 0 0 0 1
N1-C2 N1-C2 n1-c2 N N1 N1- N1-C BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 - 1 5 1 0 0 0 1
1.339(5) 1.339(5) 1.339(5) 1 1. 1.3 1.33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .() 3 7 1 0 0 0 1
1.337-1.361 1.337-1.361 1.337-1.361 1 1. 1.3 1.33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .-. 3 10 1 0 0 0 1
(1.345) (1.345) (1.345) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 (.) 3 6 1 0 0 0 1
1.312-1.321 1.312-1.321 1.312-1.321 1 1. 1.3 1.31 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .-. 3 10 1 0 0 0 1
(1.316) (1.316) (1.316) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 (.) 3 6 1 0 0 0 1
C2-C3 C2-C3 c2-c3 C C2 C2- C2-C BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 - 1 5 1 1 0 0 1
1.378(6) 1.378(6) 1.378(6) 1 1. 1.3 1.37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .() 3 7 1 1 0 0 1
1.366-1.386 1.366-1.386 1.366-1.386 1 1. 1.3 1.36 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .-. 3 10 1 1 0 0 1
(1.374) (1.374) (1.374) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (.) 3 6 1 1 0 0 1
1.333-1.392 1.333-1.392 1.333-1.392 1 1. 1.3 1.33 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .-. 3 10 1 1 0 0 1
(1.362) (1.362) (1.362) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (.) 3 6 1 1 0 0 1
C3-C4 C3-C4 c3-c4 C C3 C3- C3-C BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 - 1 5 1 1 0 0 1
1.395(5) 1.395(5) 1.395(5) 1 1. 1.3 1.39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .() 3 7 1 1 0 0 1
1.381-1.399 1.381-1.399 1.381-1.399 1 1. 1.3 1.38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .-. 3 10 1 1 0 0 1
(1.393) (1.393) (1.393) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (.) 3 6 1 1 0 0 1
1.350-1.377 1.350-1.377 1.350-1.377 1 1. 1.3 1.35 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .-. 3 10 1 1 0 0 1
(1.363) (1.363) (1.363) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (.) 3 6 1 1 0 0 1
N2-C4 N2-C4 n2-c4 N N2 N2- N2-C BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 - 1 5 1 1 0 0 1
1.320(5) 1.320(5) 1.320(5) 1 1. 1.3 1.32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .() 3 7 1 1 0 0 1
1.323-1.335 1.323-1.335 1.323-1.335 1 1. 1.3 1.32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .-. 3 10 1 1 0 0 1
(1.328) (1.328) (1.328) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (.) 3 6 1 1 0 0 1
1.330-1.343 1.330-1.343 1.330-1.343 1 1. 1.3 1.33 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .-. 3 10 1 1 0 0 1
(1.336) (1.336) (1.336) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 (.) 3 6 1 1 0 0 1
N2-N1 N2-N1 n2-n1 N N2 N2- N2-N BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 - 1 5 1 1 0 0 1
1.365(5) 1.365(5) 1.365(5) 1 1. 1.3 1.36 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .() 3 7 1 1 0 0 1
1.354-1.374 1.354-1.374 1.354-1.374 1 1. 1.3 1.35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .-. 3 10 1 1 0 0 1
(1.366) (1.366) (1.366) ( (1 (1. (1.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 (.) 3 6 1 1 0 0 1
1.341-1.355 1.341-1.355 1.341-1.355 1 1. 1.3 1.34 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 .-. 3 1 1 1 0 0 1
(1.348) (1.348) (1.348) ( (1 (1. (1.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 (.) 3 1 1 1 0 0 1
F I f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 11 [ 1 10 1 1 0 0 1
wileyonlinelibrary.com] wileyonlinelibrary.com] wileyonlinelibrary.com] w wi wil wile BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 .] 2 3 1 1 0 0 1
594 | 594 5 59 594 594 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 10 0 1 1 0 1
to the to t to to to BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 10 0 1 0 0 1
non-specific mechanism non-specific n no non non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -. 2 5 0 1 0 0 1
Looking at looking L Lo Loo Look BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 0 1 0 0 1
a few a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 0 , 1 9 0 1 0 0 1
very modest. very v ve ver very BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 2 0 1 0 0 1
In particular, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 ,, 2 9 0 1 0 0 1
containing the containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 --, 3 9 0 1 0 0 1
the O-alkylated the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -(),,, 6 9 0 1 0 0 1
showed moderate showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 1 0 0 1
range (4e: range r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (:.,.; 6 8 0 1 0 0 1
7a: EC 7a: 7 7a 7a: 7a: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 :.,.;: 6 8 0 1 0 0 1
EC 50 ec E EC EC EC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ..). 4 9 0 1 0 0 1
7a had 7a 7 7a 7a 7a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 , 1 9 0 1 0 0 1
similar selectivity similar s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 4 0 1 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 ,, 2 9 0 1 0 0 1
4-bromophenylacetamide chain 4-bromophenylacetamide 4 4- 4-b 4-br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --,, 4 9 0 1 0 0 1
selective activity selective s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (.;), 5 10 0 1 0 0 1
among the among a am amo amon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 0 1 0 0 1
chain, only chain, c ch cha chai BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,,-, 4 9 0 1 0 0 1
slight non-selective slight s sl sli slig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 -(. 3 9 0 1 0 0 1
EC 50 ec E EC EC EC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 .),. 4 5 0 1 0 0 1
As regard as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 , 1 8 0 1 0 0 1
of compound of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 , 1 9 0 1 0 0 1
exhibit a exhibit e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,- 2 9 0 1 0 0 1
rable with rable r ra rab rabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 - 1 9 0 1 0 0 1
transfected with transfected t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 ,- 2 9 0 1 0 0 1
crease in crease c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 no 0 10 0 1 0 0 1
system. system. system. s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 . 1 1 0 1 0 0 1
The low the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 - 1 8 0 1 0 0 1
gests that gests g ge ges gest BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 no 0 9 0 1 0 0 1
synthesis of synthesis s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 . 1 9 0 1 0 0 1
five-member scaffold five-member f fi fiv five BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 -- 2 8 0 1 0 0 1
rangement in rangement r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 ,- 2 9 0 1 0 0 1
ents (the ents e en ent ents BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 (- 2 8 0 1 0 0 1
group) previously group) g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 )- 2 9 0 1 0 0 1
and pyridinone and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 - 1 8 0 1 0 0 1
nists. To nists. n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 ., 2 9 0 1 0 0 1
performed. performed. performed. p pe per perf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 . 1 1 0 1 0 0 1
T A t T T T T BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 -,,,-() 7 10 0 1 0 0 1
Compd. Compd. compd. C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 . 1 10 0 0 0 0 1
R 3 r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 6 no 0 5 0 0 0 0 1
R 4 r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 6 no 0 5 0 0 0 0 1
R 5 r R R R R BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 6 no 0 5 0 0 0 0 1
EC 50 ec E EC EC EC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 ()() 4 10 0 0 0 0 1
HL60-FPR1 HL60-FPR1 hl60-fpr1 H HL HL6 HL60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 - 1 10 0 0 0 0 1
HL60-FPR2 HL60-FPR2 hl60-fpr2 H HL HL6 HL60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 - 1 10 0 0 0 0 1
hPMN hPMN hpmn h hP hPM hPMN BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 5 0 0 0 0 1
4a 4a 4a 4 4a 4a 4a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 no 0 2 0 0 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 6 no 0 1 0 0 0 0 1
CN CN cn C CN CN CN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 2 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 - 1 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 .. 2 5 0 0 0 0 1
4b 4b 4b 4 4b 4b 4b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 no 0 2 0 0 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 no 0 1 0 0 0 0 1
CN CN cn C CN CN CN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 no 0 2 0 0 0 0 1
4-OCH 3 4-och 4 4- 4-O 4-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 - 1 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
4c 4c 4c 4 4c 4c 4c BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 no 0 2 0 0 0 0 1
Ph Ph ph P Ph Ph Ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 no 0 2 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 no 0 3 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 - 1 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
4d 4d 4d 4 4d 4d 4d BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 no 0 2 0 0 0 0 1
Ph Ph ph P Ph Ph Ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 no 0 2 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 no 0 3 0 0 0 0 1
4-OCH 3 4-och 4 4- 4-O 4-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 - 1 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 .. 2 5 0 0 0 0 1
4e 4e 4e 4 4e 4e 4e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 no 0 1 0 0 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 no 0 1 0 0 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 8 no 0 1 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 - 1 8 0 0 0 0 1
13.2 ± 13.2 1 13 13. 13.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..() 4 10 0 0 0 0 1
23.4 ± 23.4 2 23 23. 23.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..() 4 10 0 0 0 0 1
8.2 ± 8.2 8 8. 8.2 8.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..() 4 9 0 0 0 0 1
7a 7a 7a 7 7a 7a 7a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 no 0 1 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 - 1 6 0 0 0 0 1
CN CN cn C CN CN CN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 no 0 1 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 no 0 3 0 0 0 0 1
18.4 ± 18.4 1 18 18. 18.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..() 4 10 0 0 0 0 1
6.1 ± 6.1 6 6. 6.1 6.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..() 4 9 0 0 0 0 1
6.5 ± 6.5 6 6. 6.5 6.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ..() 4 9 0 0 0 0 1
7b 7b 7b 7 7b 7b 7b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 no 0 2 0 0 0 0 1
4-OCH 3 4-och 4 4- 4-O 4-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 - 1 10 0 0 0 0 1
CN CN cn C CN CN CN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 no 0 2 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 no 0 4 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 .. 2 6 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 .. 2 6 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 8 .. 2 6 0 0 0 0 1
15 15 15 1 15 15 15 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 9 no 0 1 0 1 0 0 1
_ _ _ _ _ _ _ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 no 0 1 0 1 0 0 1
_ _ _ _ _ _ _ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 no 0 1 0 1 0 0 1
_ _ _ _ _ _ _ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 no 0 1 0 1 0 0 1
9.8 ± 9.8 9 9. 9.8 9.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..() 4 9 0 1 0 0 1
25.9 ± 25.9 2 25 25. 25.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..() 4 10 0 1 0 0 1
18.6 ± 18.6 1 18 18. 18.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..() 4 10 0 1 0 0 1
fMLF fMLF fmlf f fM fML fMLF BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 no 0 10 0 1 0 0 1
0.01 0.01 0.01 0 0. 0.0 0.01 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 10 0 1 0 0 1
WKYMVm WKYMVm wkymvm W WK WKY WKYM BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 no 0 10 0 1 0 0 1
0.001 0.001 0.001 0 0. 0.0 0.00 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 . 1 8 0 1 0 0 1
EC3 EC3 ec3 E EC EC3 EC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 no 0 2 0 1 0 0 1
0.019 ± 0.019 0 0. 0.0 0.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..() 4 9 0 1 0 0 1
0.043 ± 0.043 0 0. 0.0 0.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ..() 4 10 0 1 0 0 1
0.006 ± 0.006 0 0. 0.0 0.00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .. 2 7 0 1 0 0 1
(150) (150) (150) ( (1 (15 (150 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 () 2 3 0 1 0 0 1
EC10 EC10 ec10 E EC EC1 EC10 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 no 0 2 0 1 0 0 1
0.045 ± 0.045 0 0. 0.0 0.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..() 4 10 0 1 0 0 1
0.170 ± 0.170 0 0. 0.1 0.17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 ..() 4 9 0 1 0 0 1
0.036 ± 0.036 0 0. 0.0 0.03 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 .. 2 7 0 1 0 0 1
(150) (150) (150) ( (1 (15 (150 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 () 2 3 0 1 0 0 1
a a a a a a a BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 10 no 0 10 0 1 0 0 1
EC 50 ec E EC EC EC BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 -(- 3 10 0 1 0 0 1
points) generated points) p po poi poin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 )(.).() 7 9 0 1 0 0 1
5 nM 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 10 (). 3 1 0 1 0 0 1
b N.A., b b b b b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 7 10 ..,() 5 9 0 1 0 0 1
EC 50 ec E EC EC EC BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 . 1 10 0 1 0 0 1
| 595 | | | | | BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 10 0 1 1 0 1
3.4 | 3.4 3 3. 3.4 3.4 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 . 1 10 1 1 0 0 1
In order in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 no 0 9 1 1 0 0 1
with FPRs with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ( 1 9 1 1 0 0 1
et al., et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .,)(.,) 7 10 1 1 0 0 1
2a (Crocetti 2a 2 2a 2a 2a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (.,), 5 9 1 1 0 0 1
active or active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 1 1 0 0 1
ing the ing i in ing ing BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 7 0 , 1 9 1 1 0 0 1
we evaluated we w we we we BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 ,,,,,, 6 9 1 1 0 0 1
into the into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 . 1 9 1 1 0 0 1
geometries reported geometries g ge geo geom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 ., 2 9 1 1 0 0 1
sources of sources s so sou sour BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 . 1 8 1 1 0 0 1
The general the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 1 no 0 8 1 1 0 0 1
docked fMLF docked d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 (.,) 4 9 1 1 0 0 1
(secondary structure (secondary ( (s (se (sec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 ()., 4 10 1 1 0 0 1
b presents b b b b b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 7 1 no 0 10 1 1 0 0 1
T A t T T T T BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 3 ,,-- 4 10 0 1 0 0 1
Compd. Compd. compd. C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 . 1 10 0 0 0 0 1
R 1 r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 3 no 0 5 0 0 0 0 1
R 4 r R R R R BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 3 no 0 5 0 0 0 0 1
EC 50 ec E EC EC EC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 ()() 4 10 0 0 0 0 1
HL60-FPR1 HL60-FPR1 hl60-fpr1 H HL HL6 HL60 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 - 1 10 0 0 0 0 1
HL60-FPR2 HL60-FPR2 hl60-fpr2 H HL HL6 HL60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 - 1 10 0 0 0 0 1
hPMN hPMN hpmn h hP hPM hPMN BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 no 0 5 0 0 0 0 1
9b 9b 9b 9 9b 9b 9b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 no 0 3 0 0 0 0 1
p-Br-Ph- p-Br-Ph- p-br-ph- p p- p-B p-Br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 --- 3 8 0 0 0 0 1
NHCOCH 2 nhcoch N NH NHC NHCO BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
H H h H H H H BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 no 0 1 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 .. 2 4 0 0 0 0 1
23.1 ± 23.1 2 23 23. 23.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ..() 4 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 .. 2 4 0 0 0 0 1
10 10 10 1 10 10 10 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 4 no 0 3 0 0 0 0 1
p-Br-Ph- p-Br-Ph- p-br-ph- p p- p-B p-Br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 --- 3 8 0 0 0 0 1
NHCOCH 2 nhcoch N NH NHC NHCO BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 - 1 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 .. 2 5 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 .. 2 5 0 0 0 0 1
13a 13a 13a 1 13 13a 13a BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 no 0 3 0 0 0 0 1
C 3 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 no 0 7 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 - 1 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 6 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 6 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 6 0 0 0 0 1
13b 13b 13b 1 13 13b 13b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 no 0 2 0 0 0 0 1
C 3 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 no 0 4 0 0 0 0 1
3,4-(OCH 3 3,4-(och 3 3, 3,4 3,4- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ,-() 4 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 3 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 3 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 3 0 0 0 0 1
13c 13c 13c 1 13 13c 13c BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 no 0 5 0 0 0 0 1
C 3 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 no 0 10 0 0 0 0 1
4-OHPh 4-OHPh 4-ohph 4 4- 4-O 4-OH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 - 1 8 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 8 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .. 2 8 0 0 0 0 1
N.A b n.a N N. N.A N.A BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 . 1 7 0 0 0 0 1
13d 13d 13d 1 13 13d 13d BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 no 0 3 0 0 0 0 1
C 4 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 6 no 0 7 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 - 1 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 .. 2 6 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 .. 2 6 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 .. 2 6 0 0 0 0 1
13e 13e 13e 1 13 13e 13e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 no 0 2 0 0 0 0 1
C 4 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 6 no 0 4 0 0 0 0 1
3,4-(OCH 3 3,4-(och 3 3, 3,4 3,4- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 ,-() 4 10 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 .. 2 3 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 .. 2 3 0 0 0 0 1
N.A. b n.a. N N. N.A N.A. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 .. 2 3 0 0 0 0 1
13f 13f 13f 1 13 13f 13f BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 no 0 2 0 0 0 0 1
C 6 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 7 no 0 5 0 0 0 0 1
3-OCH 3 3-och 3 3- 3-O 3-OC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 - 1 6 0 0 0 0 1
20.2 ± 20.2 2 20 20. 20.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 ..() 4 10 0 0 0 0 1
10.5 ± 10.5 1 10 10. 10.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 ..() 4 10 0 0 0 0 1
13.8 ± 13.8 1 13 13. 13.8 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 ..() 4 10 0 0 0 0 1
fMLF fMLF fmlf f fM fML fMLF BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 no 0 10 0 0 0 0 1
0.01 0.01 0.01 0 0. 0.0 0.01 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 . 1 10 0 0 0 0 1
WKYMVm WKYMVm wkymvm W WK WKY WKYM BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 no 0 10 0 0 0 0 1
0.001 0.001 0.001 0 0. 0.0 0.00 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 . 1 8 0 0 0 0 1
EC3 EC3 ec3 E EC EC3 EC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 no 0 2 1 0 0 0 1
0.019 ± 0.019 0 0. 0.0 0.01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ..() 4 9 1 0 0 0 1
0.043 ± 0.043 0 0. 0.0 0.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ..() 4 10 1 0 0 0 1
0.036 ± 0.036 0 0. 0.0 0.03 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ..() 4 10 1 0 0 0 1
EC10 EC10 ec10 E EC EC1 EC10 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 no 0 2 1 0 0 0 1
0.04 5 0.04 0 0. 0.0 0.04 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ..() 4 10 1 0 0 0 1
0.170 ± 0.170 0 0. 0.1 0.17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ..() 4 9 1 0 0 0 1
0.036 ± 0.036 0 0. 0.0 0.03 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ..() 4 9 1 0 0 0 1
a a a a a a a BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 8 8 no 0 10 1 0 0 0 1
EC 50 ec E EC EC EC BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 -(- 3 10 1 0 0 0 1
points) generated points) p po poi poin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 )(.).() 7 9 1 0 0 0 1
5 nM 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 9 (). 3 1 1 0 0 0 1
b N.A., b b b b b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 8 9 ..,() 5 9 1 0 0 0 1
EC 50 ec E EC EC EC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 10 . 1 10 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 10 no 0 8 1 0 0 0 1
FPR1 homology fpr1 F FP FPR FPR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 (.,; 4 9 1 0 0 0 1
panel a). panel p pa pan pane BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 ).( 3 10 1 0 0 0 1
representation) docked representation) r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 10 ) 1 9 1 0 0 0 1
model. Residues model. m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 . 1 8 1 0 0 0 1
peptide are peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 10 ()[ 3 10 1 0 0 0 1
can be can c ca can can BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 .] 2 9 1 0 0 0 1
596 | 596 5 59 596 596 BLOCKSTART PAGESTART SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 1 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 10 1 1 1 0 1
3 Å, 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 0 ,- 2 10 1 1 0 0 1
ing site. ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 0 .() 3 9 1 1 0 0 1
into the into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 9 1 1 0 0 1
gram from gram g gr gra gram BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 9 1 1 0 0 1
from the from f fr fro from BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (.,). 5 8 1 1 0 0 1
According to according A Ac Acc Acco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 2 , 1 8 1 1 0 0 1
the fMLF the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 -,, 3 8 1 1 0 0 1
and Tyr257 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 .,- 3 9 1 1 0 0 1
tial docking tial t ti tia tial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 () 2 10 1 1 0 0 1
scoring functions. scoring s sc sco scor BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 . 1 10 1 1 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 4 no 0 6 1 1 0 0 1
complexed with complexed c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 no 0 9 1 1 0 0 1
(secondary structure; (secondary ( (s (se (sec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 (;.,; 5 10 1 1 0 0 1
panel a). panel p pa pan pane BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ). 2 9 1 1 0 0 1
peptide are peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ()[ 3 10 1 1 0 0 1
can be can c ca can can BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .] 2 9 1 1 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 6 no 0 7 1 0 0 0 1
compounds EC3 compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ()() 4 9 1 0 0 0 1
in FPR1 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 . 1 10 1 0 0 0 1
from each from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 [ 1 9 1 0 0 0 1
can be can c ca can can BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .] 2 9 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 7 no 0 7 1 0 1 1 1
poses of poses p po pos pose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 . 1 9 1 0 0 0 1
a: superimposed a: a a: a: a: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 : 1 8 1 0 0 0 1
(violet), EC10 (violet), ( (v (vi (vio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 (),(-),(- 9 9 1 0 0 0 1
blue). Residues blue). b bl blu blue BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 ). 2 9 1 0 0 0 1
are visible. are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .: 2 9 1 0 0 0 1
poses of poses p po pos pose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 (-),(-), 8 10 1 0 0 0 1
and 15 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 (). 3 9 1 0 0 0 1
4e pose 4e 4 4e 4e 4e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 .: 2 9 1 0 0 0 1
docking poses docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 (),(- 5 8 1 0 0 0 1
yellow), and yellow), y ye yel yell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 ),(). 5 9 1 0 0 0 1
3 Å 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 7 [ 1 10 1 0 0 0 1
can be can c ca can can BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .] 2 8 1 0 0 0 1
| 597 | | | | | BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 0 no 0 10 1 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 10 1 1 1 0 1
interactions according interactions i in int inte BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 1 1 0 0 1
in Supporting in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 . 1 4 1 1 0 0 1
The non-HB the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 -- 2 8 1 1 0 0 1
ture. The ture. t tu tur ture BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 9 1 1 0 0 1
residue can residue r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,-. 3 9 1 1 0 0 1
The other the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 1 1 0 0 1
an attraction an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 0 - 1 8 1 1 0 0 1
eties in eties e et eti etie BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ,(,). 5 10 1 1 0 0 1
The experimentally the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 7 0 0 0 0 1
plexed with plexed p pl ple plex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 (;.,) 5 8 0 0 0 0 1
contains five contains c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ()., 4 10 0 0 0 0 1
WKYMVm (stick wkymvm W WK WKY WKYM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 () 2 8 0 0 0 0 1
R of r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 1 (,; 3 9 0 0 0 0 1
6OMM; Zhuang 6omm; 6 6O 6OM 6OMM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ;.,). 5 4 0 0 0 0 1
Residues within residues R Re Res Resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 9 0 0 0 0 1
panel b, panel p pa pan pane BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,-, 3 8 0 0 0 0 1
Arg205, Asp281, arg205, A Ar Arg Arg2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ,,(),(). 8 8 0 0 0 0 1
strongest interaction strongest s st str stro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 9 0 0 0 0 1
analysis (Table analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 () 2 9 0 0 0 0 1
to Arg205 to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,- 2 8 0 0 0 0 1
with different with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 (,). 4 8 0 0 0 0 1
addition, the addition, a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 9 0 0 0 0 1
electrostatically interact electrostatically e el ele elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 no 0 10 0 0 0 0 1
N-H bond n-h N N- N-H N-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 -, 2 8 0 0 0 0 1
high PDS high h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 1 (). 3 7 0 0 0 0 1
According to according A Ac Acc Acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 8 0 0 0 0 1
H-bonds with h-bonds H H- H-b H-bo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 -(),(,,,, 9 8 0 0 0 0 1
10, 15), 10, 1 10 10, 10, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ,),(,,,),(,,, 13 8 0 0 0 0 1
10), or 10), 1 10 10) 10), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ),()( 5 8 0 0 0 0 1
examples in examples e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 8 0 0 0 0 1
Information). Information). information). I In Inf Info BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 ). 2 2 0 0 0 0 1
In particular, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 1 ,(.,)-- 7 9 0 0 0 0 1
teractions via teractions t te ter tera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 - 1 9 0 0 0 0 1
the acetamido the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 , 1 8 0 0 0 0 1
respectively. The respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 9 0 0 0 0 1
with Asp106, with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,.,- 4 9 0 0 0 0 1
resentative example resentative r re res rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ,- 2 9 0 0 0 0 1
centered H-bond centered c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 9 0 0 0 0 1
oxygen carbonyl oxygen o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ; 1 9 0 0 0 0 1
the 3-methoxyphenyl the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 -, 2 9 0 0 0 0 1
panel b. panel p pa pan pane BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 1 0 0 0 0 1
In this in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 1 ,- 2 9 0 0 0 0 1
drogen bonding drogen d dr dro drog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 - 1 8 0 0 0 0 1
ately active ately a at ate atel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ., 2 9 0 0 0 0 1
agonists containing agonists a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 --- 3 8 0 0 0 0 1
erocycles visibly erocycles e er ero eroc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 (,-). 5 8 0 0 0 0 1
The 4-bromophenyl the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 8 0 0 0 0 1
molecules (EC3, molecules m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 (,,,,;,,, 9 9 0 0 0 0 1
Figure 9, figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 ,) 2 9 0 0 0 0 1
the same the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,, 2 9 0 0 0 0 1
and Ile204. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,- 3 8 0 0 0 0 1
EC3, EC10, ec3, E EC EC3 EC3, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ,,(),,() 8 8 0 0 0 0 1
a pocket a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 8 1 ,,., 4 8 0 0 0 0 1
six-membered pyridazinone six-membered s si six six- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 -- 2 8 0 0 0 0 1
tent FPR1 tent t te ten tent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 ,,- 3 8 0 0 0 0 1
ferent area ferent f fe fer fere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 (,,) 4 9 0 0 0 0 1
than pyrazole than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 no 0 9 0 0 0 0 1
4e, 7a, 4e, 4 4e 4e, 4e, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ,,,. 4 9 0 0 0 0 1
In Figure in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 1 no 0 9 0 0 0 0 1
with new with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 8 0 0 0 0 1
serve this serve s se ser serv BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 . 1 3 0 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 9 no 0 8 1 0 0 0 1
(violet) and (violet) ( (v (vi (vio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 ()(). 5 9 1 0 0 0 1
within 3 within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 [ 1 10 1 0 0 0 1
wileyonlinelibrary.com] wileyonlinelibrary.com] wileyonlinelibrary.com] w wi wil wile BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 .] 2 3 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 10 , 1 8 1 1 1 1 1
EC10, 2a, ec10, E EC EC1 EC10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 ,,,,() 6 9 1 1 0 0 1
pose of pose p po pos pose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 (;.,). 6 9 1 1 0 0 1
Å 3 å Å Å Å Å BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 10 ( 1 9 1 1 0 0 1
probe size probe p pr pro prob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 .).. 4 10 1 1 0 0 1
[Colour figure [colour [ [C [Co [Col BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 10 [.] 3 7 1 1 0 0 1
598 | 598 5 59 598 598 BLOCKSTART PAGESTART SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 1 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 10 1 1 1 0 1
The inactive the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 1 1 0 0 1
a reverse a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 8 0 no 0 9 1 1 0 0 1
FPR1 agonists. fpr1 F FP FPR FPR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,- 3 8 1 1 0 0 1
(green) is (green) ( (g (gr (gre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ()-- 4 9 1 1 0 0 1
nists (violet) nists n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ()().,- 7 10 1 1 0 0 1
phobic phenyl phobic p ph pho phob BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 9 1 1 0 0 1
10 protrudes 10 1 10 10 10 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 2 no 0 10 1 1 0 0 1
cyano substituents cyano c cy cya cyan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 ,- 2 9 1 1 0 0 1
tively (see tively t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 (,). 4 5 1 1 0 0 1
An in-depth an A An An An BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 2 -- 2 8 1 1 0 0 1
count the count c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 no 0 8 1 1 0 0 1
also performed also a al als also BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 no 0 9 1 1 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 4 no 0 8 1 0 0 0 1
shown together shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 . 1 9 1 0 0 0 1
magnified views magnified m ma mag magn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 9 1 0 0 0 1
the front the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 () 2 9 1 0 0 0 1
receptor are receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 10 1 0 0 0 1
visible (rear visible v vi vis visi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ()[ 3 9 1 0 0 0 1
viewed at viewed v vi vie view BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 .] 2 7 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 6 no 0 7 1 0 0 0 1
compounds EC3 compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ()() 4 9 1 0 0 0 1
in FPR2 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 . 1 10 1 0 0 0 1
from each from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 [ 1 9 1 0 0 0 1
can be can c ca can can BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .] 2 9 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 7 no 0 8 1 0 1 0 1
poses of poses p po pos pose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 . 1 8 1 0 0 0 1
Panel a: panel P Pa Pan Pane BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 : 1 8 1 0 0 0 1
compounds EC3 compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 (),(- 5 7 1 0 0 0 1
blue), 2a blue), b bl blu blue BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 ),(-). 6 8 1 0 0 0 1
3 Å 3 3 3 3 3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 7 .: 2 9 1 0 0 0 1
superimposed docking superimposed s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 no 0 8 1 0 0 0 1
4e (light-yellow), 4e 4 4e 4e 4e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (-),(-), 8 9 1 0 0 0 1
(orange). Residues (orange). ( (o (or (ora BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 (). 3 9 1 0 0 0 1
are visible. are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .: 2 9 1 0 0 0 1
poses of poses p po pos pose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 (),(-), 7 10 1 0 0 0 1
15 (orange) 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 7 (). 3 9 1 0 0 0 1
the 4e the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 [ 1 10 1 0 0 0 1
viewed at viewed v vi vie view BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .] 2 7 1 0 0 0 1
| 599 | | | | | BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 no 0 10 1 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 10 1 1 1 0 1
orientations of orientations o or ori orie BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ., 2 10 1 1 0 0 1
FPR1 is fpr1 F FP FPR FPR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 no 0 9 1 1 0 0 1
MVD program mvd M MV MVD MVD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 8 1 1 0 0 1
The heterocyclic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 8 1 1 0 0 1
EC10, and ec10, E EC EC1 EC10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ,- 2 9 1 1 0 0 1
located between located l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 1 1 0 0 1
by low-active by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -,,., 5 9 1 1 0 0 1
compounds EC3, compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,, 2 8 1 1 0 0 1
values with values v va val valu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ( 1 9 1 1 0 0 1
Supporting Information). supporting S Su Sup Supp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 ).- 3 8 0 0 0 0 1
acts with acts a ac act acts BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ;,- 3 8 0 0 0 0 1
entation in entation e en ent enta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 .- 2 9 0 0 0 0 1
substituted benzene substituted s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
FPR1 agonists fpr1 F FP FPR FPR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 1 .- 2 8 0 0 0 0 1
sponds to sponds s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 "", 3 8 0 0 0 0 1
and was and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 9 0 0 0 0 1
size. A size. s si siz size BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 8 0 0 0 0 1
(Figure 12). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 (). 3 1 0 0 0 0 1
Docking of docking D Do Doc Dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
to docking to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 8 0 0 0 0 1
Asp106 (2a-weak asp106 A As Asp Asp1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 (--,),(-- 9 7 0 0 0 0 1
bond, 7a), bond, b bo bon bond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ,),(,,--,), 11 8 0 0 0 0 1
Ser288 (10; ser288 S Se Ser Ser2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 (;- 3 8 0 0 0 0 1
in Supporting in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 1 ). 2 4 0 0 0 0 1
When compound when W Wh Whe When BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
(PDB 6OMM; (pdb ( (P (PD (PDB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 (;.,),- 7 8 0 0 0 0 1
and Arg205 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 8 0 0 0 0 1
substituent was substituent s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 , 1 7 0 0 0 0 1
Figure 13 figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 9 0 0 0 0 1
not form not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 -., 3 8 0 0 0 0 1
docking scores, docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 , 1 9 0 0 0 0 1
der Waals der d de der der BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 ,,, 3 8 0 0 0 0 1
Asp106 of asp106 A As Asp Asp1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 , 1 8 0 0 0 0 1
agonist activity agonist a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 -. 2 5 0 0 0 0 1
The superimposed the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 7 0 0 0 0 1
ately active ately a at ate atel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 no 0 9 0 0 0 0 1
Figure 14 figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 -.,, 4 8 0 0 0 0 1
and 2a and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
positioned similarly positioned p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 : 1 10 0 0 0 0 1
4-bromophenyl and 4-bromophenyl 4 4- 4-b 4-br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 --- 3 8 0 0 0 0 1
spondingly overlaid spondingly s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 (,).- 5 8 0 0 0 0 1
containing compound containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ,- 2 8 0 0 0 0 1
oriented differently oriented o or ori orie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 9 0 0 0 0 1
The docking the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 9 0 0 0 0 1
found for found f fo fou foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ,,(,). 6 8 0 0 0 0 1
This observation this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 8 0 0 0 0 1
nist activity nist n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 - 1 9 0 0 0 0 1
tives evaluated. tives t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 . 1 9 0 0 0 0 1
docking pose docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 - 1 8 0 0 0 0 1
with that with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 , 1 9 0 0 0 0 1
protruded toward protruded p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 (, 2 8 0 0 0 0 1
and c). and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ). 2 1 0 0 0 0 1
As for as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 , 1 9 0 0 0 0 1
altered orientation altered a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 () 2 9 0 0 0 0 1
with respect with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 7 0 0 0 0 1
Regarding FPR2, regarding R Re Reg Rega BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 , 1 9 0 0 0 0 1
of 628 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 , 1 9 0 0 0 0 1
similarly to similarly s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 . 1 8 0 0 0 0 1
protein is protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ( 1 8 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ),. 3 8 0 0 0 0 1
WKYMVm is wkymvm W WK WKY WKYM BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 (). 3 5 0 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 10 no 0 9 1 0 0 0 1
(violet) and (violet) ( (v (vi (vio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 ()()( 5 10 1 0 0 0 1
6OMM). Residues 6omm). 6 6O 6OM 6OMM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 ).[ 3 9 1 0 0 0 1
figure can figure f fi fig figu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 .] 2 7 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 10 , 1 8 1 1 1 0 1
EC10, 2a, ec10, E EC EC1 EC10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 ,,,,() 6 9 1 1 0 0 1
an experimentally an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 10 (; 2 8 1 1 0 0 1
6OMM). A 6omm). 6 6O 6OM 6OMM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 ).( 3 10 1 1 0 0 1
MVD software mvd M MV MVD MVD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 .)[ 3 9 1 1 0 0 1
at wileyonlinelibrary.com] at a at at at BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 .] 2 3 1 1 0 0 1
600 | 600 6 60 600 600 BLOCKSTART PAGESTART SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 1 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 10 1 1 1 0 1
Again, p-bromo again, A Ag Aga Agai BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,- 2 9 1 1 0 0 1
moderately active moderately m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 10 1 1 0 0 1
hole of hole h ho hol hole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 1 1 0 0 1
(except compound (except ( (e (ex (exc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (--) 4 9 1 1 0 0 1
in Figure in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 0 . 1 2 1 1 0 0 1
4 | 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 10 0 0 0 0 1
In conclusion, in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 0 , 1 9 0 0 0 0 1
pyrazolone derivatives pyrazolone p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ., 2 9 0 0 0 0 1
most of most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 0 0 0 0 1
nist activity, nist n ni nis nist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 , 1 9 0 0 0 0 1
appropriate for appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
on these on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,- 2 8 0 0 0 0 1
able different able a ab abl able BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 0 0 0 1
site of site s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -- 2 8 0 0 0 0 1
dazinones/pyridinones versus dazinones/pyridinones d da daz dazi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 /-- 3 9 0 0 0 0 1
pyrazoles/pyrazolones have pyrazoles/pyrazolones p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 /., 3 8 0 0 0 0 1
comparing binding comparing c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,,(- 4 8 0 0 0 0 1
membered core, membered m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,), 3 8 0 0 0 0 1
7a, and 7a, 7 7a 7a, 7a, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ,(/), 5 9 0 0 0 0 1
it is it i it it it BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 10 0 0 0 0 1
ity (4-bromophenyl ity i it ity ity BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (-- 3 8 0 0 0 0 1
group), occupy group), g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ), 2 8 0 0 0 0 1
(Leu156, Arg201 (leu156, ( (L (Le (Leu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 (,,,, 5 8 0 0 0 0 1
Gln258). Moreover, gln258). G Gl Gln Gln2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ).,- 4 8 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 0 0 0 1
branch of branch b br bra bran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 0 ""- 3 9 0 0 0 0 1
truding into truding t tr tru trud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
difference between difference d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 0 0 0 1
rangement in rangement r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -- 2 9 0 0 0 0 1
pared with pared p pa par pare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -, 2 8 0 0 0 0 1
satisfactorily explain satisfactorily s sa sat sati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 0 0 0 1
pyrazoles and pyrazoles p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ., 2 9 0 0 0 0 1
compound 10 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 0 0 0 0 1
4-bromophenylacetamide chain 4-bromophenylacetamide 4 4- 4-b 4-br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 - 1 9 0 0 0 0 1
with respect with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,/ 2 9 0 0 0 0 1
complete inactivity. complete c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .- 2 9 1 1 0 0 1
bonds is bonds b bo bon bond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 5 no 0 9 1 1 0 0 1
probably other probably p pr pro prob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 9 1 1 0 0 1
this case, this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,- 2 9 1 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 5 no 0 9 1 1 0 0 1
the main the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 10 1 1 0 0 1
pyrazole derivatives. pyrazole p py pyr pyra BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 . 1 3 1 1 0 0 1
5 | 5 5 5 5 5 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 7 no 0 10 0 0 0 0 1
The following the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 ,- 2 8 0 0 0 0 1
pounds 4a, pounds p po pou poun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 ,,,,,,,,(-); 12 10 0 0 0 0 1
selected view selected s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 no 0 9 0 0 0 0 1
15 interacting 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 7 ();- 4 9 0 0 0 0 1
bonds in bonds b bo bon bond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 ()- 3 9 0 0 0 0 1
ment parameters ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (); 3 9 0 0 0 0 1
of EC10, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ,,,, 4 9 0 0 0 0 1
and superimposed and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (-);- 5 9 0 0 0 0 1
sis of sis s si sis sis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 () 2 9 0 0 0 0 1
functions for functions f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ()( 3 9 0 0 0 0 1
and S6). and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 ). 2 1 0 0 0 0 1
ACKNOWLEDGMENTS ACKNOWLEDGMENTS acknowledgments A AC ACK ACKN BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 2 0 0 0 0 1
The authors the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 10 0 0 0 0 1
PDB file pdb P PD PDB PDB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 no 0 10 0 0 0 0 1
docked fMLF docked d do doc dock BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 3 0 0 0 0 1
CONFLICT OF conflict C CO CON CONF BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 4 0 0 0 0 1
The authors the T Th The The BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 . 1 10 0 0 0 0 1
AUTHOR CONTRIBUTIONS author A AU AUT AUTH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 3 0 0 0 0 1
L. Crocetti, l. L L. L. L. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 .,..,. 6 9 0 0 0 0 1
the compounds the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 ;.,. 4 9 0 0 0 0 1
Guerrini, and guerrini, G Gu Gue Guer BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 ,. 2 9 0 0 0 0 1
checked the checked c ch che chec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 .- 2 10 0 0 0 0 1
ies and ies i ie ies ies BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 .. 2 9 0 0 0 0 1
Kirpotina, I.A. kirpotina, K Ki Kir Kirp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 ,..,... 7 9 0 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 11 no 0 7 1 0 0 0 1
receptor is receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 11 . 1 10 1 0 0 0 1
Ordinary and ordinary O Or Ord Ordi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 no 0 9 1 0 0 0 1
surface from surface s su sur surf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 11 () 2 10 1 0 0 0 1
sides of sides s si sid side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 11 no 0 8 1 0 0 0 1
the hole the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 11 (). 3 9 1 0 0 0 1
WKYMVm peptide wkymvm W WK WKY WKYM BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 7 1 0 0 0 1
| 601 | | | | | BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 10 0 1 1 0 1
docking was docking d do doc dock BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ... 3 9 0 1 0 0 1
analysis and analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 1 0 0 1
P. Paoli. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .. 2 10 0 1 0 0 1
approval of approval a ap app appr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 6 0 1 0 0 1
ORCID ORCID orcid O OR ORC ORCI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 2 0 1 0 0 1
Gabriella Guerrini gabriella G Ga Gab Gabr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 0 no 0 7 0 1 0 0 1
https://orcid. https://orcid. https://orcid. h ht htt http BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 1 10 0 ://. 4 6 0 1 0 0 1
org/0000-0001-6711-7965 org/0000-0001-6711-7965 org/0000-0001-6711-7965 o or org org/ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 /--- 4 10 0 1 0 0 1
REFERENCES REFERENCES references R RE REF REFE BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
Arakawa, K., arakawa, A Ar Ara Arak BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.().- 12 8 0 1 0 0 1
erocyclic compounds. erocyclic e er ero eroc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .. 2 8 0 1 0 0 1
3-methylpyrazol-5-one. Chemical 3-methylpyrazol-5-one. 3 3- 3-m 3-me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ---.,, 6 8 0 1 0 0 1
207-213. https://doi.org/10.1248/cpb.22.207 207-213. 2 20 207 207- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -.://././.. 11 5 0 1 0 0 1
Baraldi, P. baraldi, B Ba Bar Bara BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,..,,.,,., 17 9 0 1 0 0 1
Baraldi, S., baraldi, B Ba Bar Bara BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,..,,.,,., 16 8 0 1 0 0 1
& Borea, & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 ,..().()-[()/()-- 17 8 0 1 0 0 1
methoxy-phenyl]-(2-chloro)-5′-N-ethylcarboxamido-adenosines: methoxy-phenyl]-(2-chloro)-5′-N-ethylcarboxamido-adenosines: methoxy-phenyl]-(2-chloro)-5′-n-ethylcarboxamido-adenosines: m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -]-(-)----: 11 8 0 1 0 0 1
The first the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 -- 2 8 0 1 0 0 1
onist activity onist o on oni onis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 (). 3 8 0 1 0 0 1
& Medicinal & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 ,,-.://././. 12 8 0 1 0 0 1
bmc.2007.01.055 bmc.2007.01.055 bmc.2007.01.055 b bm bmc bmc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ... 3 2 0 1 0 0 1
Boulay, F., boulay, B Bo Bou Boul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.(). 14 9 0 1 0 0 1
and use and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 8 0 1 0 0 1
N-formyl peptide n-formyl N N- N-f N-fo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -. 2 8 0 1 0 0 1
Research Communications, research R Re Res Rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 0 ,,-.://. 8 7 0 1 0 0 1
org/10.1016/0006-291X(90)91143 -G org/10.1016/0006-291x(90)91143 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 /./-()- 7 4 0 1 0 0 1
Bozinovski, S., bozinovski, B Bo Boz Bozi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,..,,..,,. 16 9 0 1 0 0 1
D., & d., D D. D., D., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,.(). 7 8 0 1 0 0 1
COPD by copd C CO COP COPD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 /. 2 8 0 1 0 0 1
& Therapeutics, & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 ,,-.://././. 12 8 0 1 0 0 1
thera.2013.07.007 thera.2013.07.007 thera.2013.07.007 t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ... 3 2 0 1 0 0 1
Bruker. (2012a). bruker. B Br Bru Bruk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .()... 6 6 0 1 0 0 1
Bruker. (2012b). bruker. B Br Bru Bruk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .()... 6 6 0 1 0 0 1
Burli, R. burli, B Bu Bur Burl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,.,,.,,.,,.,, 20 9 0 1 0 0 1
M., Plant, m., M M. M., M., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,..,,.,,.,,.,, 16 8 0 1 0 0 1
V. N., v. V V. V. V. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,,.,,.().()- 14 8 0 1 0 0 1
onists as onists o on oni onis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -. 2 8 0 1 0 0 1
Chemistry Letters, chemistry C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,-.://././. 12 8 0 1 0 0 1
bmcl.2006.04.068 bmcl.2006.04.068 bmcl.2006.04.068 b bm bmc bmcl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ... 3 2 0 1 0 0 1
Cilibrizzi, A., cilibrizzi, C Ci Cil Cili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,..,,.,, 14 9 0 1 0 0 1
C., Bartolucci, c., C C. C., C., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,.,,.,,..,,.., 16 9 0 1 0 0 1
Faggi, C. faggi, F Fa Fag Fagg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.().,,- 8 8 0 1 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 --- 3 8 0 1 0 0 1
tide receptor tide t ti tid tide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ().,,-.://. 11 8 0 1 0 0 1
org/10.1002/chir.22162 org/10.1002/chir.22162 org/10.1002/chir.22162 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 /./. 4 3 0 1 0 0 1
Cilibrizzi, A., cilibrizzi, C Ci Cil Cili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,..,,..,,.., 15 8 0 1 0 0 1
Holderness, J., holderness, H Ho Hol Hold BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,..,,..,,.,,., 17 9 0 1 0 0 1
Graziano, A., graziano, G Gr Gra Graz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.,, 13 9 0 1 0 0 1
M. P. m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..().--,--()-: 14 8 0 1 0 0 1
novel class novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -- 2 8 0 1 0 0 1
tors. Journal tors. t to tor tors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,-.://. 9 8 0 1 0 0 1
org/10.1021/jm900 592h org/10.1021/jm900 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 /./ 3 3 0 1 0 0 1
Cilibrizzi, A., cilibrizzi, C Ci Cil Cili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,..,,.,,.,, 14 10 0 1 0 0 1
V., Giovannoni, v., V V. V., V., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,..,,.,,..,,. 15 8 0 1 0 0 1
T., & t., T T. T., T., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,.().,,- 10 8 0 1 0 0 1
ity profile ity i it ity ity BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 --,--()- 8 8 0 1 0 0 1
ones as ones o on one ones BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -. 2 8 0 1 0 0 1
Medicinal Chemistry, medicinal M Me Med Medi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,-.://././. 12 8 0 1 0 0 1
bmc.2012.04.043 bmc.2012.04.043 bmc.2012.04.043 b bm bmc bmc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ... 3 2 0 1 0 0 1
Cooray, S., cooray, C Co Coo Coor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,-,.,,., 13 8 0 1 0 0 1
Thompson, D., thompson, T Th Tho Thom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,,.,,.(). 14 8 0 1 0 0 1
Ligand-specific conformational ligand-specific L Li Lig Liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 --- 3 8 0 1 0 0 1
receptor ALX/FPR2 receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 /. 2 8 0 1 0 0 1
Proceedings of proceedings P Pr Pro Proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,, 2 8 0 1 0 0 1
18232-18237. https://doi.org/10.1073/pnas.13082 18232-18237. 1 18 182 1823 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 -.://././. 10 7 0 1 0 0 1
Crocetti, L., crocetti, C Cr Cro Croc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,,.,,.,,. 14 10 0 1 0 0 1
I., Kirpotina, i., I I. I., I., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,..,,..,,..,, 15 9 0 1 0 0 1
M. P. m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..(). 5 8 0 1 0 0 1
pyridazin-based thioderivatives pyridazin-based p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 -() 3 8 0 1 0 0 1
agonists. Drug agonists. a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,-.://. 9 8 0 1 0 0 1
org/10.1016/j.bmc.2011.06.036 org/10.1016/j.bmc.2011.06.036 org/10.1016/j.bmc.2011.06.036 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 /./.... 7 4 0 1 0 0 1
Crocetti, L., crocetti, C Cr Cro Croc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,,.,,.,,.., 16 10 0 1 0 0 1
Schepetkin, I. schepetkin, S Sc Sch Sche BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..,,..,,.,, 12 9 0 1 0 0 1
L., Ghelardini, l., L L. L., L., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,.,,..().- 12 8 0 1 0 0 1
tide receptors tide t ti tid tide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ()- 3 8 0 1 0 0 1
dione scaffold dione d di dio dion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 10 5 no 0 9 0 1 0 0 1
arthritis. Bioorganic arthritis. a ar art arth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-.://. 9 9 0 1 0 0 1
org/10.1016/j.bioorg.2020 org/10.1016/j.bioorg.2020 org/10.1016/j.bioorg.2020 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 /./.. 5 3 0 1 0 0 1
Cussel, P. cussel, C Cu Cus Cuss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,...,,..,,..,,.., 17 9 0 1 0 0 1
Milton, N. milton, M Mi Mil Milt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,...,,...(). 12 9 0 1 0 0 1
receptor agonist receptor r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
neuroblastoma cells neuroblastoma n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 9 0 1 0 0 1
be specifically be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
using siRNA. using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-.://././ 12 8 0 1 0 0 1
al.pone.0217815 al.pone.0217815 al.pone.0217815 a al al. al.p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 .. 2 2 0 1 0 0 1
Dal Piaz, dal D Da Dal Dal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 5 ,.,,..,,...,,..,, 17 9 0 1 0 0 1
F. J., f. F F. F. F. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,,..,,.(). 12 8 0 1 0 0 1
pyridazin-3(2H)-one as pyridazin-3(2h)-one p py pyr pyri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -()-(), 7 8 0 1 0 0 1
PCT International pct P PC PCT PCT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 . 1 6 0 1 0 0 1
Farrugia, L. farrugia, F Fa Far Farr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..().--- 9 8 0 1 0 0 1
III with iii I II III III BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 (). 3 8 0 1 0 0 1
Crystallography, 30, crystallography, C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,.://././ 10 8 0 1 0 0 1
7003117 7003117 7003117 7 70 700 7003 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 no 0 1 0 1 0 0 1
Giovannoni, M. giovannoni, G Gi Gio Giov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..,,..,,.,,., 14 9 0 1 0 0 1
Khlebnikov, A. khlebnikov, K Kh Khl Khle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..,,.,,.,,.,, 14 9 0 1 0 0 1
L. N., l. L L. L. L. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,,.,,.,,..(). 15 9 0 1 0 0 1
studies on studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 --()-:, 7 9 0 1 0 0 1
and evaluation and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,-- 3 9 0 1 0 0 1
tors (FPRs) tors t to tor tors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ().,, 5 9 0 1 0 0 1
512-528. https://doi.org/10.1016/j.ejmech.2013.03.066 512-528. 5 51 512 512- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -.://././.... 13 7 0 1 0 0 1
Groom, C. groom, G Gr Gro Groo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,..,,..,,..,,..(). 18 9 0 1 0 0 1
Cambridge structural cambridge C Ca Cam Camb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ., 2 8 0 1 0 0 1
72, 171-179. 72, 7 72 72, 72, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,-.://././ 10 7 0 1 0 0 1
Huang, J., huang, H Hu Hua Huan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,,.,,.,,..,, 17 8 0 1 0 0 1
O. M. o. O O. O. O. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ...,,.,,.,,..(). 16 8 0 1 0 0 1
the leucocyte the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 1 0 0 1
by cell by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,,-.://. 9 9 0 1 0 0 1
org/10.1093/carci n/bgn266 org/10.1093/carci o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 /.// 4 3 0 1 0 0 1
Katritzky, A. katritzky, K Ka Kat Katr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..,,..().- 11 9 0 1 0 0 1
omatic compounds omatic o om oma omat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 --:- 4 8 0 1 0 0 1
pyrazolin-5-ones. Tetrahedron, pyrazolin-5-ones. p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 --.,,-.://. 11 7 0 1 0 0 1
org/10.1016/S0040 -4020(01)93217 org/10.1016/s0040 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 /./-()- 7 4 0 1 0 0 1
Krause, L., krause, K Kr Kra Krau BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,-,.,,..,,.(). 16 9 0 1 0 0 1
Comparison of comparison C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 8 0 1 0 0 1
for single-crystal for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -. 2 8 0 1 0 0 1
Crystallography, 48, crystallography, C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,-.://././ 11 8 0 1 0 0 1
4022985 4022985 4022985 4 40 402 4022 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 5 no 0 1 0 1 0 0 1
602 | 602 6 60 602 602 BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 10 0 1 1 0 1
Krepel, S. krepel, K Kr Kre Krep BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..(). 10 9 0 1 0 0 1
G-Protein-coupled formylpeptide g-protein-coupled G G- G-P G-Pr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 --. 3 8 0 1 0 0 1
of Molecular of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,-.://././ 11 8 0 1 0 0 1
ijms2 0143426 ijms2 i ij ijm ijms BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 no 0 1 0 1 0 0 1
Lacy, M., lacy, L La Lac Lacy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,..,,..,,.., 18 9 0 1 0 0 1
& Barnum, & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 ,..(). 6 8 0 1 0 0 1
anaphylatoxin, interleukin-8 anaphylatoxin, a an ana anap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ,- 2 8 0 1 0 0 1
microglia. Journal microglia. m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,-.://. 9 8 0 1 0 0 1
org/10.1016/0165-5728(95)00075 -D org/10.1016/0165-5728(95)00075 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 /./-()- 7 4 0 1 0 0 1
Lind, S., lind, L Li Lin Lind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.,,., 15 9 0 1 0 0 1
Olofsson, P. olofsson, O Ol Olo Olof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.(). 5 9 0 1 0 0 1
the neutrophil the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -. 2 8 0 1 0 0 1
Pharmacology, Pharmacology, pharmacology, P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 , 1 1 0 1 0 0 1
166, 166, 166, 1 16 166 166, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 , 1 0 0 1 0 0 1
163-173. 163-173. 163-173. 1 16 163 163- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 1 0 1 0 0 1
https://doi.org/10.1016/j. https://doi.org/10.1016/j. https://doi.org/10.1016/j. h ht htt http BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 10 0 ://././. 8 3 0 1 0 0 1
bcp.2019.04.030 bcp.2019.04.030 bcp.2019.04.030 b bc bcp bcp. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ... 3 2 0 1 0 0 1
Liu, J., liu, L Li Liu Liu, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.,,.,,.,,.,, 22 9 0 1 0 0 1
B., Wang, b., B B. B., B., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,.,,.,,.().- 14 8 0 1 0 0 1
tor suppresses tor t to tor tor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 - 1 8 0 1 0 0 1
gration. Inflammation, gration. g gr gra grat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,-.://././ 12 9 0 1 0 0 1
3-014-9819-z 3-014-9819-z 3-014-9819-z 3 3- 3-0 3-01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 --- 3 1 0 1 0 0 1
Macrae, C. macrae, M Ma Mac Macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..,,..,,..,, 17 9 0 1 0 0 1
P., Pidcock, p., P P. P., P., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,.,-,.,,.,,., 15 9 0 1 0 0 1
& Wood, & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 ,..()..-- 9 8 0 1 0 0 1
alization and alization a al ali aliz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 9 0 1 0 0 1
Crystallography, 41, crystallography, C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,-.://././ 11 9 0 1 0 0 1
7067908 7067908 7067908 7 70 706 7067 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 no 0 1 0 1 0 0 1
Maris, J. maris, M Ma Mar Mari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..().. 7 8 0 1 0 0 1
England Journal england E En Eng Engl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 0 ,,-.://. 8 7 0 1 0 0 1
org/10.1056/NEJMr a0804577 org/10.1056/nejmr o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 /./ 3 3 0 1 0 0 1
Migeotte, I., migeotte, M Mi Mig Mige BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.(). 11 9 0 1 0 0 1
receptors: A receptors: r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 :- 2 9 0 1 0 0 1
controlling immune controlling c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ., 2 8 0 1 0 0 1
17, 501-519. 17, 1 17 17, 17, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,-.://././.... 14 8 0 1 0 0 1
Migeotte, I., migeotte, M Mi Mig Mige BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,..,,.,,., 16 9 0 1 0 0 1
Wittamer, V., wittamer, W Wi Wit Witt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,., 12 8 0 1 0 0 1
Vassart, G. vassart, V Va Vas Vass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.().- 6 8 0 1 0 0 1
dogenous chemotactic dogenous d do dog doge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 8 0 1 0 0 1
Experimental Medicine, experimental E Ex Exp Expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,-.://././ 11 8 0 1 0 0 1
jem.20041277 jem.20041277 jem.20041277 j je jem jem. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 . 1 1 0 1 0 0 1
Nardelli, M. nardelli, N Na Nar Nard BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.().-: 7 8 0 1 0 0 1
Fortran routines fortran F Fo For Fort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 8 0 1 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 9 0 1 0 0 1
Crystallography, 28, crystallography, C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,.://././ 10 8 0 1 0 0 1
5007138 5007138 5007138 5 50 500 5007 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 no 0 1 0 1 0 0 1
O'Brain, D. o'brain, O O' O'B O'Br BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ',..,,..(). 11 7 0 1 0 0 1
3-hydroxy-1-phenylpyrazole. Journal 3-hydroxy-1-phenylpyrazole. 3 3- 3-h 3-hy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ---.,, 6 8 0 1 0 0 1
1538-1542. https://doi.org/10.1021/jo013 1538-1542. 1 15 153 1538 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 -.://././ 9 6 0 1 0 0 1
Odobasic, D., odobasic, O Od Odo Odob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.,,.,,.,,., 21 9 0 1 0 0 1
Kitching, A. kitching, K Ki Kit Kitc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,..,,..,,.. 15 8 0 1 0 0 1
(2018). Formyl (2018). ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 (). 3 9 0 1 0 0 1
effector T effector e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
models of models m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ., 2 9 0 1 0 0 1
61, 140-149. 61, 6 61 61, 61, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,-.://././.... 14 7 0 1 0 0 1
Perretti, M., perretti, P Pe Per Perr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,..,-,.(). 16 9 0 1 0 0 1
Resolution pharmacology: resolution R Re Res Reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 : 1 9 0 1 0 0 1
in inflammation. in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 0 .,,-. 5 9 0 1 0 0 1
Prevete, N., prevete, P Pr Pre Prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,..,,. 15 9 0 1 0 0 1
(2015). Formyl (2015). ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()., 4 9 0 1 0 0 1
angiogenesis and angiogenesis a an ang angi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .,, 3 8 0 1 0 0 1
184-191. https://doi.org/10.1016/j.phrs.2015.09.017 184-191. 1 18 184 184- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -.://././.... 13 7 0 1 0 0 1
Prevete, N., prevete, P Pr Pre Prev BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,.,,.,,.,,.,, 16 10 0 1 0 0 1
A. (2005). a. A A. A. A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 .().- 5 8 0 1 0 0 1
sor function sor s so sor sor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 . 1 8 0 1 0 0 1
Oncogene, 34, oncogene, O On Onc Onco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,,-.://././.. 13 8 0 1 0 0 1
Sheldrick, G. sheldrick, S Sh She Shel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,..().. 7 7 0 1 0 0 1
Crystallography, 64, crystallography, C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 ,,-.://././ 11 8 0 1 0 0 1
7043930 7043930 7043930 7 70 704 7043 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 5 no 0 1 0 1 0 0 1
Sheldrick, G. sheldrick, S Sh She Shel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,..().. 7 8 0 1 0 0 1
Acta Crystallography, acta A Ac Act Acta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,,-.://././ 11 8 0 1 0 0 1
4024218 4024218 4024218 4 40 402 4024 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 5 no 0 1 0 1 0 0 1
Snapkov, I., snapkov, S Sn Sna Snap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,..,,.,,.,,.., 17 9 0 1 0 0 1
& Sveinbjornsson, & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 5 ,.(). 5 8 0 1 0 0 1
1 (FPR1) 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 11 5 ().,,- 6 7 0 1 0 0 1
501. https://doi.org/10.1186/s1288 501. 5 50 501 501. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .://././--- 11 6 0 1 0 0 1
Sodin-Semrl, S., sodin-semrl, S So Sod Sodi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 -,.,,.,,.,,.,,., 16 8 0 1 0 0 1
Fiore, S. fiore, F Fi Fio Fior BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.().-- 7 8 0 1 0 0 1
kappaB responses kappab k ka kap kapp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 - 1 8 0 1 0 0 1
mon lipoxin mon m mo mon mon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 . 1 8 0 1 0 0 1
and Pharmacology, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ,,-.://././ 11 7 0 1 0 0 1
32004 01700206 32004 3 32 320 3200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 5 no 0 1 0 1 0 0 1
Stalder, A. stalder, S St Sta Stal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,..,,.,,..,,..,,.,, 19 10 0 1 0 0 1
P. M. p. P P. P. P. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ...,,.().,- 11 7 0 1 0 0 1
guided clinical guided g gu gui guid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 --- 3 8 0 1 0 0 1
FPR2/ALX agonist fpr2/alx F FP FPR FPR2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 /-. 3 7 0 1 0 0 1
Pharmacology, 83, pharmacology, P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,,-.://././. 12 7 0 1 0 0 1
Uhlen, M., uhlen, U Uh Uhl Uhle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,.,,..,,.,,., 16 9 0 1 0 0 1
Mardinoglu, A., mardinoglu, M Ma Mar Mard BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,.,,.,,.,, 13 8 0 1 0 0 1
A., Olsson, a., A A. A., A., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 .,,.,,.,,.,,.,, 15 8 0 1 0 0 1
C.-A.-K., Odeberg, c.-a.-k., C C. C.- C.-A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 .-.-.,,.,,.,,..,,., 19 8 0 1 0 0 1
… Ponten, … … … … … BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 5 ,.()..- 7 8 0 1 0 0 1
proteome. Science, proteome. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .,,.://././ 11 8 0 1 0 0 1
ce.1260419 ce.1260419 ce.1260419 c ce ce. ce.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 . 1 1 0 1 0 0 1
Van Compernolle, van V Va Van Van BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 5 ,.,,.,,.,,.(). 14 8 0 1 0 0 1
Expression and expression E Ex Exp Expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 - 1 8 0 1 0 0 1
broblast cells. broblast b br bro brob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .,,-.://. 9 8 0 1 0 0 1
org/10.4049/jimmu nol.171.4.2050 org/10.4049/jimmu o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 /./... 6 4 0 1 0 0 1
Vergelli, C., vergelli, V Ve Ver Verg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,..,,.,,.,,., 16 9 0 1 0 0 1
Giovannoni, M. giovannoni, G Gi Gio Giov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,..,,.,,.,,.., 14 8 0 1 0 0 1
Khlebnikov, A. khlebnikov, K Kh Khl Khle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,..,,..,,..().- 15 8 0 1 0 0 1
mido-4-phenylamino-5-substituted pyridazinones mido-4-phenylamino-5-substituted m mi mid mido BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ---- 4 8 0 1 0 0 1
receptors agonists. receptors r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 .,,- 4 8 0 1 0 0 1
2543. https://doi.org/10.1016/j.bmc.2016.04.019 2543. 2 25 254 2543 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 .://././.... 12 6 0 1 0 0 1
Vergelli, C., vergelli, V Ve Ver Verg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,..,,.,,.,,., 16 9 0 1 0 0 1
Giovannoni, M. giovannoni, G Gi Gio Giov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,..,,.,,.,,..,, 15 8 0 1 0 0 1
R. D., r. R R. R. R. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ..,,..().-- 11 8 0 1 0 0 1
N-phenylacetamido substituted n-phenylacetamido N N- N-p N-ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 -- 2 8 0 1 0 0 1
ceptor agonists. ceptor c ce cep cept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .,,-.://. 9 8 0 1 0 0 1
org/10.1002/ddr.21076 org/10.1002/ddr.21076 org/10.1002/ddr.21076 o or org org/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 5 /./. 4 2 0 1 0 0 1
Wen, X., wen, W We Wen Wen, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,.,,.,,.,,.,,.,,., 21 8 0 1 0 0 1
& Jin, & & & & & BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 5 ,.().-- 7 8 0 1 0 0 1
a dual a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 11 5 . 1 8 0 1 0 0 1
Molecular Biology molecular M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 ,,-.://././ 11 8 0 1 0 0 1
mbcE1 8-06-0358 mbce1 m mb mbc mbcE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 -- 2 2 0 1 0 0 1
Xiang, Y., xiang, X Xi Xia Xian BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,.,,.,,.,,.,,.,,.,, 19 9 0 1 0 0 1
T., Huang, t., T T. T., T., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 .,,.,,.,,.().- 14 8 0 1 0 0 1
chemoattractant receptor chemoattractant c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 no 0 8 0 1 0 0 1
human colon human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ., 2 8 0 1 0 0 1
6, 2599-2610. 6, 6 6, 6, 6, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ,-. 3 1 0 1 0 0 1
Ye, R. ye, Y Ye Ye, Ye, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 ,..,,.,,..,,.,,.,, 18 9 0 1 0 0 1
M., Serhan, m., M M. M., M., BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 .,,...,,.(). 12 8 0 1 0 0 1
| 603 | | | | | BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 0 no 0 10 0 1 0 0 1
VERGELLI Et vergelli V VE VER VERG BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 . 1 10 0 1 1 0 1
of Basic of o of of of BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .. 2 9 0 0 0 0 1
formyl peptide formyl f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ()., 4 9 0 0 0 0 1
61, 119-161. 61, 6 61 61, 61, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-.://././.. 12 7 0 0 0 0 1
Zhuang, Y., zhuang, Z Zh Zhu Zhua BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.,,.,,..,,..,,..,, 19 10 0 0 0 0 1
W., Xu, w., W W. W., W., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,..,,.,,.,,.,,.,,., 21 9 0 0 0 0 1
Fan, H., fan, F Fa Fan Fan, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,.,,..,,..,,.(). 16 9 0 0 0 0 1
of formylpeptide of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -- 2 9 0 0 0 0 1
gand recognition gand g ga gan gand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,. 4 9 0 0 0 0 1
https://doi.org/10.1038/s4146 7-020-14728 https://doi.org/10.1038/s4146 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 0 ://././--- 10 6 0 0 0 0 1
SUPPORTING INFORMATION supporting S SU SUP SUPP BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 4 0 1 0 0 1
Additional supporting additional A Ad Add Addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 10 0 1 0 0 1
the Supporting the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 6 0 1 0 0 1
How to how H Ho How How BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 7 :,.,,. 6 9 0 0 0 0 1
I., Crocetti, i., I I. I., I., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 7 .,,.,,.,,.,,. 13 10 0 0 0 0 1
N., Schepetkin, n., N N. N., N., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 7 .,,..,,.,,.., 13 8 0 0 0 0 1
Rossi, P., rossi, R Ro Ros Ross BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 7 ,.,,.,,..(). 12 8 0 0 0 0 1
Synthesis, biological synthesis, S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 7 ,,, 3 9 0 0 0 0 1
and structural and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 7 no 0 7 0 0 0 0 1
pyrazolone derivatives pyrazolone p py pyr pyra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 7 - 1 8 0 0 0 0 1
agonists. Chemical agonists. a ag ago agon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 7 .,, 3 7 0 0 0 0 1
582-603. https://doi.org/10.1111/cbdd.13913 582-603. 5 58 582 582- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 -.://././. 10 7 0 0 0 0 1

